Name: 123441-03-2|(S)-3-(1-(Dimethylamino)ethyl)phenyl ethyl(methyl)carbamate|98%
Brand: Ambeed
SKU: A248924
Price: 38.0 USD
Availability: InStock
Rating: 93 (26 reviews)

1
[ 123441-03-2 ]
N-ethyl-N-methyl-3-[1-(dimethylamino)ethyl]carbamic acid phenyl-2-3H-ester [ No CAS ]

Reference： [1]Journal of labelled compounds and radiopharmaceuticals,1997,vol. 39,p. 651 - 668

2
[ 1016225-06-1 ]
[ 624-78-2 ]
[ 123441-03-2 ]

Yield	Reaction Conditions	Operation in experiment
62%	In dichloromethane; at 20℃; for 2.5 - 3h;Product distribution / selectivity;	Example 4; Synthesis of the compound (L-R); Reaction scheme:Process:1 g 3-(l-(Dimethylamino)ethyl) phenol was dissolved in 20 ml dichloromethane (distilled from CaCl2). The solution was cooled with an ice-water bath (0-50C). 0.92 g trie thy lamine was added.2.21 g bis(4-nitrophenyl)carbonate was added. The yellow solution was stirred in an ice- water bath.[0062] Reaction progress was monitored by HPLC. After 4 hours, 715 mg N- ethylmethylamine was added and the yellow solution was stirred for 17 hours at 40C. The reaction mixture was allowed to warm to room temperature and was then washed with 2x20 ml water. The organic phase was concentrated in vacuo. To the resulting yellow oil, 20 ml diethyl ether and 20 ml of a solution of hydrochloric acid (2 M) were added. The 2- phase system was stirred for 15 minutes. The acidic aqueous layer was washed with 20 ml diethyl ether.[0063] 20 ml dichloromethane was added to the aqueous layer and a solution of sodium hydroxide (2 M) was added until pH~12 was reached. The organic layer was washed with 2x20 ml water, dried (Na2SO4), filtered and concentrated in vacuo. Isolated yield: 1.37 g (90%), yellow oilHPLC: 98% purity1H-NMR: confirmed the expected structure; Example 12; Synthesis of rivastigmine (Ia); Reaction scheme:L NH <n="22"/>[0078] 0.5 g (S)-3-(l-(Dimethylamino)ethyl) phenol was dissolved in 10 ml dichloromethane (distilled from CaCl2).[0079] 1. Ig bis(4-nitrophenyl)carbonate was added. The yellow solution was stirred at ambient temperature.[0080] Reaction progress was monitored with HPLC. After 1.5 hour, 357 mg N- ethylmethylamine was added dropwise and the yellow solution was stirred at ambient temperature for 2.5 hours. The reaction mixture was concentrated in vacuo. To the resulting yellow oil, 10 ml diethyl ether and 10 ml of a solution of hydrochloric acid (2 M) were added. The 2-phase system was stirred for 10 minutes. The acidic aqueous layer was washed with 10 ml diethyl ether.[0081] 10 ml dichloromethane was added to the aqueous layer and a solution of sodium hydroxide (2 M) was added until pH~12 was reached. The organic layer was washed with 2x10 ml water, dried (Na2SO4), filtered and concentrated in vacuo.Isolated yield: 0.58 g (76%), yellow oilHPLC: 94 % purity; Example 13; Synthesis of Rivastigmine; [0082] 0.5 g (S)-3-(l-(Dimethylamino)ethyl) phenol was dissolved in 10 ml dichloromethane (distilled from CaCl2).[0083] 1.11 g bis(4-nitrophenyl)carbonate was added. The yellow solution was stirred at ambient temperature.[0084] Reaction progress was monitored by HPLC. After 1.5 hours, 357 mg N- ethylmethylamine was added dropwise and the yellow solution was stirred for 2.5 hours at <n="23"/>ambient temperature. The reaction mixture was concentrated in vacuo. To the resulting yellow oil, 10 ml diethyl ether and 10 ml of a solution of hydrochloric acid (2 M) were added. The 2-phase system was stirred for 10 minutes. The acidic aqueous layer was washed with 10 ml diethyl ether. [0085] 20 ml dichloromethane was added to the aqueous layer and a solution of sodium hydroxide (2 M) was added until pH~12 was reached. The organic layer was washed with 2x10 ml water, dried (Na2SO4), filtered and concentrated in vacuo. Isolated yield: 0.58 g (76%), yellow oilHPLC: 93.92% purity, 99% ee

Reference： [1]Patent: WO2008/37433,2008,A1 .Location in patent: Page/Page column 15-16; 19-21

3
[ 123441-03-2 ]
(S)-N-ethyl-N-methyl-3-[1-(dimethylamino)ethyl]carbamic acid phenyl-2-3H-ester [ No CAS ]

Reference： [1]Journal of labelled compounds and radiopharmaceuticals,1997,vol. 39,p. 651 - 668

4
[ 87-69-4 ]
[ 123441-03-2 ]
(S)-(-)-rivastigmine hydrogenartrate [ No CAS ]

Yield	Reaction Conditions	Operation in experiment
80%	In methanol; acetone;	2.0 g of base (II) and 1.2 g of L- (+)-tartaric acid are dissolved in 5 ml of methanol at 60 C. The clear solution is left to cool down to room temperature and it is gradually precipitated with acetone (ca 50 ml). The resulting mixture is left to crystallize at +5 C overnight. The deposited crystals are sucked off using fritted glass and washed with acetone. They are dried in vacuo at 40 C and 2.4 g of white crystals (80% of the theoretical yield) with m. p. = 123-5 C are obtained. The obtained results differed according to the used method of resolving substance IV. The method with 1 equivalent amount of (S)- (+)-CAMPHOR-10-SULFONIC acid provided a total yield of 16.2 % based on compound IV and that with 0.6 equivalent provided a total yield of 19.5 % based on compound IV.
68.4 - 92.6%	In ethanol; ethyl acetate;	8.86 g of the base (II) and 5.31 g of L- (+)-tartaric acid are dissolved under warm conditions and stirring in 20 ml of ethanol and the clear solution is precipitated with addition of ethylacetate (250 ml). The resulting mixture is left to cool down to +5 C. The precipitated crystals are sucked away and washed with ethylacetate. 9.7 g of desired <strong>[123441-03-2]rivastigmin</strong>e HYDROGENTARTRATE (I) RESULTS (I. E. , 68.4 % OF THE THEORETICAL YIELD) WITH M. P. = 124-126 C. THE CONTENTS OF THE UNDESIRED (R) -ENANTIOMER IN THIS FRACTION WAS 1 % (AS DETERMINED BY CAPILLARY electrophoresis). 0.3 g of the hydrogentartrate were recrystallized from a mixture ethanol/ethylacetate in the above specified manner and 0.24 g of a recrystallized fraction (I) were obtained (80 %). The CONTENTS OF THE UNDESIRED (R) -ENANTIOMER HAS DECREASED TO 0.69 % (CAPILLARY ELECTROPHORESIS). A total yield, based on the starting material (IV), of 12.5 % has been obtained. Preparation of S- (-)-RIVASTIGMINE (II) 300 ml of tetrahydrofuran (THF) are placed in a 0.51-three-neck flask and sodium hydride as a 60% dispersion in oil (11.3 g) is added slowly under inert conditions (Ar or N2) and stirring. A suspension develops, to which crystalline compound (III) (46.5 g, 0.281 mol) is added at room temperature. A solution of the phenolate forms, to which 35.7 g (0.281 mol) of carbamoylchloride are added dropwise over 10 minutes while slightly cooling down to 15 C. The reaction is slightly exothermic. The rate of dropping is kept such that the temperature of the reaction mixture does not exceed 30 C. After all the agent is added, the cooling system is put aside and the reaction mixture is mixed for 2 hours at room temperature. Thereafter, THF is evaporated in a rotary vacuum evaporator. The evaporation residue is partitioned between 200 ml 1N NAOH and 500 ml of ether. The organic layer is separated and the aqueous fraction is shaken with additional 2x 200 ml of ether. The combined ether layers are shaken out with lx 100 ml water and lx 50 ml brine. The organic fraction is dried over anhydrous sodium sulfate. The solvent is evaporated and the crude product is vacuum distilled. b. p. = 135-140 C at 13 Pa 45.6 g of a colorless viscous oil are obtained, i. e. a 80.5% yield. content GC 99.6% Preparation of S- (-) <strong>[123441-03-2]rivastigmin</strong>e (II) 150 ml of diethylether are placed in a 0.51-three-neck flask and sodium hydride as a 60% dispersion in oil (0.48 g) is added slowly under inert conditions (Ar or N2) and stirring. A suspension develops, to which crystalline compound (III) (2.0 g, 0.012 mol) is added at room temperature. After stirring for one hour, a slightly turbid solution of the phenolate forms, to which 1.53 g (0.012 mol) OF N-ETHYL-N-METHYLCARBAMOYLCHLORIDE in 20 ml of ether are added dropwise at room temperature. The resulting reaction mixture is stirred at room temperature for 3 hours. Thereafter, it is diluted with 100 ml of water. The organic layer is separated and extracted with 2x 50 ml of a 0.1 N NAOH solution. The organic phase is extracted with 50 ml of water, dried with anhydrous magnesium sulfate, and concentrated in vacuo. 2.6 g of an oil are obtained (86.6% of the theoretical yield). Preparation of S- (-) <strong>[123441-03-2]rivastigmin</strong>e (II) 50 ml 1,2-dimethoxyethane are placed in a 0.251 round three-neck flask and compound (III) (2.0 g, 0.012 mol) is dissolved therein under stirring and under an inert (Ar or N2) at room temperature. Then, a 1.6M solution of n-butyllithium in hexane (7.5 ml) is added dropwise to the resulting solution. A slightly turbid solution of the phenolate develops, to which 1.53 g (0.012 mol) of N-ethyl-N-methylcarbamoylchloride in 20 ml of 1,2-dimethoxyethane are added dropwise at room temperature. The solvent is evaporated in a rotary vacuum evaporator. The evaporation residue is partitioned between 20 ml 1N NAOH and 50 ML of ether. The organic layer is separated and the aqueous fraction is shaken with additional 2x 20 ml of ether. The combined ether layers are shaken with lx 20 ml water and lx 20 ml brine. The organic fraction is dried over anhydrous sodium sulfate and concentrated in vacuo. 1.56 g of an oil are obtained (51.5% of the theoretical yield).

Reference： [1]Patent: WO2004/37771,2004,A1 .Location in patent: Page 13, 14
[2]Patent: WO2004/37771,2004,A1 .Location in patent: Page 7, 12, 13, 14

5
(S)-rivastigmine di-p-toluoyl tartrate [ No CAS ]
[ 123441-03-2 ]

Yield	Reaction Conditions	Operation in experiment
	With sodium hydroxide; In hexane; water; at 0 - 5℃; for 0.5h;	To the solution of 200 gm (0.8 moles) [RACEMIC] Rivastigmine base in 2.0 L Methanol: [ WATER (2: 1), WAS ADDED 322.0 GM (0.8 MOLES) (+) -DI-P-TOLUOYL TARTARIC ACID] monohydrate and resulting slurry was heated to [60-65C] for 30 minutes to get clear solution. After cooling to [0-5C,] precipitated solid was filtered, dried at [50-55C] and recrystallized 4 times from minimum volumes of Methanol: water (2: 1) to get optically pure di-p-toluoyl tartrate salt of (S)-enantiomer of Rivastigmine. (Specific optical rotation=80-81. [5,] c=5 in Methanol) The above prepared salt was added in portions to a mixture of 1 N [NAOH] solution and n-hexane at [0-5C] temperature, stirred for 30 minutes, and organic phase was separated. Organic phase was then washed twice with water and concentrated [ COMPLETELY TO GET OPTICALLY PURE (S) -ENANTIOMER OF RIVASTIGMINE. (SPECIFIC OPTICAL] [ROTATION=-32,] c=5 in Methanol)
	With sodium hydroxide; In water; at 5 - 30℃; for 0.416667h;	Liberation of Rivasti; 12ml of aqueous 1N NaOH solution (0. 12mol) was charged to a flask equipped with a thermometer pocket and ice-bath. The solution was cooled to 5C and 2g (0. 0031mol) of the DPTTA salt obtained after three crystallisations above was charged to it. The ice-bath was removed and after 10 minutes of stirring the solution became turbid (at about 12C) and was allowed to come to 30C in about 15 minutes. It was extracted with diethyl ether (3 x 15ml) and the combined organic extracts were dried over sodium sulphate and concentrated to dryness on the rotavapor to obtain 750mg of rivastigmine (1). Yield: 750mg, 98.2%. [a] D (c=5 methanol)-30. 29.'H NMR: 8 1.16-1. 25 (2 x t, 3H, N-CH2CH3), 8 1.35 (d, 3H, PhCCH3), 8 2.2 (s, 6H, N- (CH3)), 8 2.90 and 3.00 (2 x s, 3H, N-CH3), 8 3.21-3. 27 (q, 2H, CHCH3), 8 3.39-3. 48 (2 x q, 2H, N- CH2CH3), 8 7.0 (d, 1H, Ar-H), 8 7. 06 (s, 1H, Ar-H), 8 7. 11 (d, 1H, Ar-H), 8 7.28 (t, 1H, Ar-H).

Reference： [1]Patent: WO2003/101917,2003,A2 .Location in patent: Page 12
[2]Patent: WO2005/61446,2005,A2 .Location in patent: Page/Page column 16

6
C₁₃H₂₀N₂O₂*C₁₈H₁₈O₆ [ No CAS ]
[ 123441-03-2 ]

Yield	Reaction Conditions	Operation in experiment
85%	With sodium hydroxide; In dichloromethane; water;	The salt of S- (-)-rivastigmine (II) with (+)-O, O'-DITOLUYLTARTARIC acid (33.0 g) is slowly added to the well mixed mixture of 150 ml of dichloromethane and 150 ml of IN NAOH solution. After all the solids are dissolved, the layers are separated; the dichloromethane layer is extracted twice with 100 ml of water, dried with magnesium sulfate. The solvent is evaporated in vacuo and the evaporation residue is distilled under vacuum (b. p. = 135-8 C, 40 Pa). 10.72 g of a colorless oil are obtained, which is 85% of the theoretical yield ( [A] D - 24. 5 ; C=3. 5, methanol).

Reference： [1]Patent: WO2004/37771,2004,A1 .Location in patent: Page 7

7
[ 42252-34-6 ]
[ 123441-03-2 ]

Yield	Reaction Conditions	Operation in experiment
86.6%		150 ml of diethylether are placed in a 0.51-three-neck flask and sodium hydride as a 60% dispersion in oil (0.48 g) is added slowly under inert conditions (Ar or N2) and stirring. A suspension develops, to which crystalline compound (III) (2.0 g, 0.012 mol) is added at room temperature. After stirring for one hour, a slightly turbid solution of the phenolate forms, to which 1.53 g (0.012 mol) OF N-ETHYL-N-METHYLCARBAMOYLCHLORIDE in 20 ml of ether are added dropwise at room temperature. The resulting reaction mixture is stirred at room temperature for 3 hours. Thereafter, it is diluted with 100 ml of water. The organic layer is separated and extracted with 2x 50 ml of a 0.1 N NAOH solution. The organic phase is extracted with 50 ml of water, dried with anhydrous magnesium sulfate, and concentrated in vacuo. 2.6 g of an oil are obtained (86.6% of the theoretical yield).
80.5%		300 ml of tetrahydrofuran (THF) are placed in a 0.51-three-neck flask and sodium hydride as a 60% dispersion in oil (11.3 g) is added slowly under inert conditions (Ar or N2) and stirring. A suspension develops, to which crystalline compound (III) (46.5 g, 0.281 mol) is added at room temperature. A solution of the phenolate forms, to which 35.7 g (0.281 mol) of carbamoylchloride are added dropwise over 10 minutes while slightly cooling down to 15 C. The reaction is slightly exothermic. The rate of dropping is kept such that the temperature of the reaction mixture does not exceed 30 C. After all the agent is added, the cooling system is put aside and the reaction mixture is mixed for 2 hours at room temperature. Thereafter, THF is evaporated in a rotary vacuum evaporator. The evaporation residue is partitioned between 200 ml 1N NAOH and 500 ml of ether. The organic layer is separated and the aqueous fraction is shaken with additional 2x 200 ml of ether. The combined ether layers are shaken out with lx 100 ml water and lx 50 ml brine. The organic fraction is dried over anhydrous sodium sulfate. The solvent is evaporated and the crude product is vacuum distilled. b. p. = 135-140 C at 13 Pa 45.6 g of a colorless viscous oil are obtained, i. e. a 80.5% yield. content GC 99.6%
80.5%		Reference example 1: Preparation of S-(-)-Rivastigmine; 300ml of tetrahydrofuran (THF) are placed in a 0.51 -three-neck flask and sodium hydride as a 60% dispersion in oil (11.3g) is added slowly under inert conditions (Ar or N2) and stirring. A suspension develops, to which alpha-m-hydroxy phenylethyldimethylamine (46.5g, 0.28 lmol) is added at room temperature. A solution of the phenolate forms, to which 35.7g (0.28 lmol) of carbamoylchloride are added dropwise over 10 minutes while slightly cooling down to 150C. The reaction is slightly exothermic. The rate of dropping is kept such that the temperature of the reaction mixture does not exceed 30C. After all the agent is added, the cooling system is put aside and the reaction mixture is mixed for 2 hours at room temperature. Thereafter, THF is evaporated in a rotary vacuum evaporator. The evaporation residue is partitioned between 200 ml IN NaOH and 500 ml of ether. The organic layer is separated and the aqueous fraction is shaken with additional 2x 200 ml of ether. The combined ether layers are shaken out with Ix 100 ml water and Ix 50 ml brine. The organic fraction is dried over anhydrous sodium sulfate. The solvent is evaporated and the crude product is vacuum distilled. b. p. =135-140oC at l3 Pa 45.6 g of a colorless viscous oil are obtained, i.e. a 80.5% yield. Content GC 99.6%

51.5%

50 ml 1,2-dimethoxyethane are placed in a 0.251 round three-neck flask and compound (III) (2.0 g, 0.012 mol) is dissolved therein under stirring and under an inert (Ar or N2) at room temperature. Then, a 1.6M solution of n-butyllithium in hexane (7.5 ml) is added dropwise to the resulting solution. A slightly turbid solution of the phenolate develops, to which 1.53 g (0.012 mol) of N-ethyl-N-methylcarbamoylchloride in 20 ml of 1,2-dimethoxyethane are added dropwise at room temperature. The solvent is evaporated in a rotary vacuum evaporator. The evaporation residue is partitioned between 20 ml 1N NAOH and 50 ML of ether. The organic layer is separated and the aqueous fraction is shaken with additional 2x 20 ml of ether. The combined ether layers are shaken with lx 20 ml water and lx 20 ml brine. The organic fraction is dried over anhydrous sodium sulfate and concentrated in vacuo. 1.56 g of an oil are obtained (51.5% of the theoretical yield).

Reference： [1]Patent: WO2004/37771,2004,A1 .Location in patent: Page 13
[2]Patent: WO2004/37771,2004,A1 .Location in patent: Page 12
[3]Patent: WO2008/20452,2008,A1 .Location in patent: Page/Page column 9
[4]Patent: WO2004/37771,2004,A1 .Location in patent: Page 13

8
[ 87-69-4 ]
[ 123441-03-2 ]
[ 123441-03-2 ]

Yield	Reaction Conditions	Operation in experiment
92.6%	In ethanol; ethyl acetate; at 60 - 70℃;	Reference example 2: Preparation of <strong>[123441-03-2]Rivastigmine</strong> hydrogentartrate; 45.6g of S-(-)-<strong>[123441-03-2]rivastigmin</strong>e and 27.4g of L- (+)-tartaric acid are dissolved in 125ml of anhydrous ethanol at 60-70C under stirring. At this temperature, 630ml of ethylacetate are gradually added to the solution. The solution is left to cool down to room temperature and to crystallize at +5C for at least 12 hours. The precipitated white crystalline product is sucked off, washed with 100ml of ethylacetate, and vacuum dried at 4O0C. 67.5g of the desired product with m.p.=125-126C (i.e. 92.6 % of the theoretical yield). ([a]D = +5.5; c=5, ethanol).
92.6%	In ethanol; at 60 - 70℃;	Reference Example 2Preparation of <strong>[123441-03-2]Rivastigmine</strong> Hydrogentartrate45.6 g of S-(-)-<strong>[123441-03-2]rivastigmin</strong>e and 27.4 g of L-(+)-tartaric acid are dissolved in 125 ml of anhydrous ethanol at 60-70 C. under stirring. At this temperature, 630 ml of ethylacetate are gradually added to the solution. The solution is left to cool down to room temperature and to crystallize at +5 C. for at least 12 hours. The precipitated white crystalline product is sucked off, washed with 100 ml of ethylacetate, and vacuum dried at 40 C. 67.5 g of the desired product with m.p.=125-126 C. (i.e. 92.6% of the theoretical yield). ([a]D=+5.5; c=5, ethanol).
91%	In propylene glycol; at 90℃;	(2) the 1 dissolved in the product 180ml1.2-propylene glycol, by adding L-(+) tartaric acid (18g, 0.12mol), heating 90 C stirring, to the clear reaction solution, for natural cooling to room temperature under stirring, separate products, filtering, drying the finished product weight tartaric acid of <strong>[123441-03-2]Rivastigmine</strong> 42.5g, yield 91%.

85%	In acetone; at 60℃; for 1h;	(-)-S-3-[l-(dimethylamino)ethyl]phenyl-N-ethyl-N-methylcarbamate (I) (100gms;1.0 mole) and L-tartaric acid (60gms; l.Omole) were added to acetone (1000ml) and the mixture heated at 600C for 1.0 hour to get a clear mixture, which was then cooled for EPO <DP n="14"/>complete precipitation of the tartrate salt of compound (I). The tartrate salt of compound was filtered and dried. Yield: 135 gms. %Yield: 85%. HPLC Purity: 99%.
83%	In acetone; at 20℃; for 0.666667h;Reflux;	Embodiment 22 The Preparation of <strong>[123441-03-2]Rivastigmine</strong> (Formula I) Mix 5.0 g (0.02 mol) (S)-3-(1-(dimethylamino)ethyl)phenyl ethyl(methyl)carbamate (formula X) with 20 ml acetone and 3.0 g L-tartaric acid (0.02 mol) at room temperature, heat the mixture until it refluxes, and let it react for 40 min. After it is cooled to 40 C., add seed crystals and stir it at room temperature for 2 hours. Use ice bath for insulation for 5 hours and set it in a refrigerator overnight. Filter it, and set it in a vacuum oven at 40 C. for 10 hours to receive 6.64 g white crystals with a yield of 83%. HPLC purity?99.8%, ee value of ?99.8%. Optical rotation [alpha]20D=+ 6.0 (C=5, ethanol); mp 123.8-124.5 C. 1HNMR (CDCl3) delta: 1.16, 1.24 (2t, 3H), 1.67 (d, 3H), 2.65 (s, 6H), 2.96, 3.05 (2s, 3H), 3.37, 3.45 (2*q, 2H), 4.34 (q, 1H), 4.47 (s, 2H), 7.14 (t, 1H), 7.20 (s, 1H), 7.28 (d, 1H), 7.39 (t, 1H); MS (ESI) m/z: 251.2 ([M+1]+).
83%	In acetone; for 0.666667h;Reflux;	Mix 5.0 g (0.02 mol) (S)-3-(1-(dimethylamino)ethyl)phenyl ethyl(methyl)carbamate (formulaX) with 20 ml acetone and 3.0 g L-tartaric acid (0.02 mol) at room temperature, heat the mixture until it refluxes, and let it react for 40 min. After it is cooled to 40 C, add seed crystals and stir it at room temperature for 2 hours. Use ice bath for insulation for 5 hours and set it in a refrigerator overnight. Filter it, and set it in a vacuum oven at 40 C for 10 hours to receive 6.64 g white crystals with a yield of 83%. HPLC purity > 99.8%, ee value of ? 99.8%. Optical rotation [alpha]20D = +6.0 (C = 5, ethanol); mp 123.8-124.5 C. 1HNMR (CDCl3) delta: 1.16,1.24 (2xt,3H), 1.67 (d,3H), 2.65 (s,6H), 2.96,3.05 (2xs,3H), 3.37,3.45 (2xq,2H), 4.34 (q,1H), 4.47 (s,2H), 7.14 (t,1H), 7.20 (s,1H), 7.28 (d,1H), 7.39 (t,1H); MS (ESI) m/z: 251.2 ([M+1]+).
81.5%	In isopropyl alcohol;Heating;	Add 350 ml of isopropanol, 76 g of intermediate 2, 51.4 g of L(+) tartaric acid to a 1L reaction flask, stir and heat untilflow. Then cooled to room temperature, crystallized 2h, suction filtration, filter cake rinsed with a small amount of isopropanol, to obtain crude <strong>[123441-03-2]rivastigmin</strong>e <strong>[123441-03-2]rivastigmin</strong>e. willThe solid wet product obtained in the previous step was added to a 1L reaction flask, 350 ml of acetone was added, and the mixture was stirred at room temperature for 1 hour. Then filter, filter cake with a small amountRinse with acetone and dry to give 99.1 g of a white solid. Yield 81.5%, R isomer 0.11%.
78%	In methanol; acetone; at 40℃;Reflux;	Example 10: Preparation of <strong>[123441-03-2]rivastigmin</strong>e (the compound represented by formula (VIII)); 117.5ml acetone and 2.83g (18.9mmol) L-tartaric acid were added into 4.72g (18.9mmol) the compound represented by formula (VII). The mixture was heated to 40C, followed by adding 11.8ml methanol, and refluxed for 40 min. After the mixture was cooled to 40C, seed crystal was added was and the mixture was stirred at room temperature for 2 hours. Then the mixture was settled in an ice bath for 5 hours followed by standing in a refrigerator overnight. After filtering and drying in a vacuum oven at 40C for 9 hours, white crystal (5.89g) was obtained with a yield of 78%. HPLC purity =99.8%, ee%=99.8% Optical rotation [alpha]20D = +6.0, C=5, ethanol; mp 122.3-124.1C. 1H NMR (CDCl3) delta ppm: 1.24, 1.16 (2×t, 3H), 1.67 (d, 3H), 2.65 (s, 6H), 2.96, 3.05(2xs, 3H), 3.37, 3.45(2×q, 2H), 4.34 (q, 1H), 4.47 (s, 2H), 7.14 (t, 1H), 7.20 (s, 1H), 7.28 (d, 1H), 7.39 (t, 1H); MS (ESI) m/z: 251.2.
77%	In methanol; at 8 - 55℃;Product distribution / selectivity;	Biva. rtigmine bydrogen tartrate (9); Methanol (0. 4ml) was taken in a glass vial and L- (+)-tartaric acid (0.204g, 1. 36mmol, leq) was added to it. It was warmed to about 40-45C to get a clear solution. This was added to a flask containing 0. 34g <strong>[123441-03-2]rivastigmin</strong>e (1) (1. 36mmol, leq). The clear solution was heated to 55C for about 5 minutes and kept at 30C for 2 hours and at 8-10C overnight. The solvent was evaporated to dryness and the oil so obtained was triturated with hexanes (1 x 5ml, 2 x 10ml) to obtain a solid that was filtered off under vacuum on a sintered funnel under an atmosphere of nitrogen. Yield: 419mg, 77%. [a] D (c=5 methanol) +5. 02.'H NMR: 8 1.05-1. 18 (2 x t, 3H, N-CH2CH3), 8 1.53 (d, 3H, PhCCH3), 8 2. 54 (s, 6H, N- (CH3) , 8 2.87 and 2.99 (2 x s, 3H, N-CH3), 8 3. 24-3.43 (2 x q, 2H, N-CH2CH3), 8 4.22-4. 29 (q, 2H, CHCH3), 8 7.15 (d, 1H, Ar-H), 8 7.22 (s, 1H, Ar-H), 8 7.31 (d, 1H, Ar-H), 8 7.46 (t, 1H, Ar-H).
76%	In ethyl acetate; at 20 - 60℃; for 2h;	L+Tartaric acid ( 8gm 0.052 mol) in Methanol 20 ml and Solution of III (13.5 gm 0.06 1 mol) inEthyl acetate 60 ml is added to above solution at 50-60C. The mass is stined for 2 hrs at 20-25C and filtered at 0-5C. The wet cake is refluxed in Acetone 100 ml. Final product is isolated after cooling to 0-5C followed by acetone wash. Obtained yield 76%.Chiral HPLC: R isomer 0.19% S Isomer 99.8% HPLC purity: 99.98% (figures 15 and 16).
	In acetone; for 1h;Heating / reflux;Product distribution / selectivity;	(S)-3-(l-dimethylaminoethyl)phenol hydrochloride (hydrochloride of the compound of Formula 8, 30 g, 0.148 mol) was suspended in acetonitrile (150 ml), and then N-ethyl-N-methylcarbamoyl chloride (36.1 g, 0.297 mol) was added thereto. The resulting solution was cooled to 0C. To the solution was added sodium hydride (29.7 g, 60%, 0.743 mol). The temperature was gradually allowed to rise to room temperature. The reaction mixture was stirred at room temperature for 24 hours. The completion of the reaction was confirmed by HPLC. The reaction mixture was extracted with ether, and organic layer was concentrated. Water and hydrochloric acid were added thereto. After the resulting mixture was stirred at room temperature for 2 hours, it was washed twice with ether. The obtained aqueous layer was concentrated and crystallized from ethylacetate, affording (S)-<strong>[123441-03-2]rivastigmin</strong>e hydrochloride (22.28g, 52%). The (S)-<strong>[123441-03-2]rivastigmin</strong>e hydrochloride (18.5 g, 64.5 mmol) was dissolved in water (60 ml), and then NaOH (2.58 g, 64.5 mmol, 1 eq.) was added thereto. The reaction mixture was stirred for 30 minutes. The mixture was extracted twice with ether, dried over anhydrous MgSO 4 , and concentrated under reduced pressure. The concentrate was distilled under vacuum at 116-128C to obtain <strong>[123441-03-2]rivastigmin</strong>e (10.7 g, 66.3%) as a pure distillate. To the distillate were sequentially added acetone (30 ml) and L-tartaric acid (6 g, 40 mmol, 1 eq.). The mixture was refluxed for one hour, cooled to 00C, and filtered to obtain a solid. The solid was washed, and dried to afford (S)-<strong>[123441-03-2]rivastigmin</strong>e tartrate salt2 (16 g, 93.5% from the <strong>[123441-03-2]rivastigmin</strong>e hydrochloride, 99.8% ee).[59] In addition, the same results were obtained when(S)-3-(l-dimethylaminoethyl)phenol (Formula 8, Example 2) in the free-base form was used instead of (S)-3-(l-dimethylaminoethyl)phenol hydrochloride (hydrochloride salt of the compound of Formula 8).[60] n : (S)-<strong>[123441-03-2]rivastigmin</strong>e[61] ' H NuMR (CDCl3): 7.29 (IH, m), 7.01 (3H, m), 3.44 (2H, q), 3.24 (IH, q), 3.02(3H, d), 2.20 (6H, s), 1.35 (3H, d), 1.21 (3H, m)[62] 2 : (S)-<strong>[123441-03-2]rivastigmin</strong>e tartrate salt: m.p 124C
	In acetone; at 30 - 60℃; for 2.5h;Heating / reflux;	EXAMPLE 6: PREPARATION OF RIVASTIGMINE TARTRATE (FORMULA I); 3 kg of <strong>[123441-03-2]rivastigmin</strong>e freebase of Formula II in 105 lit of acetone, 1.8 kg of L-(+)-Tartaric acid was charged and heated to about 60 C followed by stirring for about 30 minutes for complete dissolution. The resulting reaction solutions was passed through celite and wash the bed with 13.5 lit acetone to made particle free. The obtained clear solution was distilled off up to 50% of the initial volume and cooled to 30C. 12 g of <strong>[123441-03-2]rivastigmin</strong>e hydrogen tartrate was added and stirred for about 60 minutes. The reaction mixture was heated to reflux and stirred for about 60 minutes and cooled to about 30C and stirred for about 60 minutes for solid separation. The separated solid was filtered and washed the solid with 3 lit of acetone. Solid obtained was dried at about 60 C for about 9 hours to afford 4.10 kg of the title compound. Purity by HPLC: 97.37%.
	In acetone; at 30 - 60℃; for 2.5h;Heating / reflux;	Example 6; Preparation Of <strong>[123441-03-2]Rivastigmine</strong> Tartrate (Formula I); 3 kg of <strong>[123441-03-2]rivastigmin</strong>e freebase of Formula II in 105 lit of acetone, 1.8 kg of L-(+)-Tartaric acid was charged and heated to about 60 C. followed by stirring for about 30 minutes for complete dissolution. The resulting reaction solutions was passed through celite and wash the bed with 13.5 lit acetone to made particle free. The obtained clear solution was distilled off up to 50% of the initial volume and cooled to 30 C. 12 g of <strong>[123441-03-2]rivastigmin</strong>e hydrogen tartrate was added and stirred for about 60 minutes. The reaction mixture was heated to reflux and stirred for about 60 minutes and cooled to about 30 C. and stirred for about 60 minutes for solid separation. The separated solid was filtered and washed the solid with 3 lit of acetone. Solid obtained was dried at about 60 C. for about 9 hours to afford 4.10 kg of the title compound.Purity by HPLC: 97.37%.
	In isopropyl alcohol; at 20 - 80℃;Product distribution / selectivity;	EXAMPLE 6; Preparation of crystalline form of (S)-N-Ethyl-N-methyl-3-[1-(dimethylamino)ethyl]-phenyl carbamate (2R,3R)-hydrogen tartrate; (2R,3R)-Tartaric acid (9.0 g, 60.0 mmol) was added to a solution of <strong>[123441-03-2](S)-N-ethyl-N-methyl-3-[1-(dimethylamino)ethyl]phenyl carbamate</strong> (15.0 g, 60.0 mmol) in isopropyl alcohol (75 mL). The resulting mixture was heated to 75-80 C. and then cooled to 20-25 C. The resulting suspension was filtered and washed with isopropanol and the solid was dried under vacuum at 40-50 C. to give crystalline (S)-N-Ethyl-N-methyl-3-[1-(dimethylamino)ethyl]-phenyl carbamate (2R,3R)-hydrogen tartrate (<strong>[123441-03-2]Rivastigmine</strong> hydrogen tartrate) 1H NMR (CDCl3) delta 8.50-7.50 (s, 4H); 7.41 (t, J=7.8 Hz 1H); 7.30-7.16 (m, 3H); 4.44 (s, 2H); 4.34 (q, J=6.5 Hz, 1H); 3.50-3.34 (m, 2H); 3.02 (ad, 3H); 2.66 (s, 6H); 1.70 (d, J=6.8 Hz); 1.26-1.15 (m, 3H). PXRD (FIG. 1).; EXAMPLE 7 Preparation of (S)-N-Ethyl-N-methyl-3-[1-(dimethylamino)ethyl]-phenyl carbamate (2R,3R)-hydrogen tartrate from (S)-3-[1-(Dimethylamino)ethyl]phenol and 1-[(N-ethyl-methylamino)carbonyl]-3-methyl-1H-imidazolium methyl sulfate Triethylamine (3.6 g, 35.4 mmol) and 1-{([N-ethyl-(N-methyl)amino]carbonyl}-3-methyl-1H-imidazolium methyl sulfate (9.1 g, 32.6 mmol) were added slowly to the cooled solution of (S)-3-[1-(dimethylamino)ethyl]phenol (4.5 g, 27.23 mmol) in acetonitirile (25 mL). The reaction mixture was stirred at 75-80 C. until reaction completion as determined by 1H NMR. The reaction mixture was evaporated and the obtained residue was diluted with water (30 mL) and toluene (30 mL) and then basified with 50% aq. NaOH solution at internal temperature below 10 C. The phases were separated and the aqueous phase was extracted with toluene. The combined organic phases were washed with water. The organic solution was evaporated under vacuum to give <strong>[123441-03-2](S)-N-ethyl-N-methyl-3-[1-(dimethylamino)ethyl]phenyl carbamate</strong>. The residue dissolved in isopropanol (45 mL) and to the solution was added (2R,3R)-tartaric acid (4.08 g, 27.23 mmol) and heated to 70-80 C. The solution was cooled and the resulting suspension was filtered and dried to give (S)-N-Ethyl-N-methyl-3-[1-(dimethylamino)ethyl]-phenyl carbamate (2R,3R)-hydrogen tartrate (8.54 g, 78% yield). The 1H NMR spectrum of the product was identical to that of example 6. EXAMPLE 8 Preparation of amorphous form of (S)-N-Ethyl-N-methyl-3-[1-(dimethylamino)ethyl]phenyl carbamate hydrogen-(2R,3R)-tartrate The solution of (S)-N-Ethyl-N-methyl-3-[1-(dimethylamino)ethyl]-phenyl carbamate hydrogen-(2R,3R)-tartrate (<strong>[123441-03-2]Rivastigmine</strong> hydrogen tartrate) (2 g) in water (4 mL) was stirred at 20-25 C. for 0.5-1 hour. The mixture was evaporated at 45-60 C. under vacuum to give a white solid. The obtained material was further dried at 40-45 C. for 10-12 hours under vacuum to obtain amorphous <strong>[123441-03-2]Rivastigmine</strong> hydrogen tartrate.
	In acetone; at 50℃; for 0.5h;	Example 2: Preparation <strong>[123441-03-2]Rivastigmine</strong> Hydrogentartarate salt22 gm of the <strong>[123441-03-2]Rivastigmine</strong> (+) DPTTA salt obtained as 2nd crop in Example 1 Step (c) was charged in a flask containing 150 ml of water and pH was adjusted to about 11 using about 20 ml of aqueous ammonia. The reaction mixture was extracted with dichloromethane(DCM) (250 ml) and the organic layer was washed with water (100 ml). The final organic layer was distilled completely to obtain 9.5 gm of <strong>[123441-03-2]Rivastigmine</strong> base as residue.25 ml of acetone was added to the above obtained residue and stirred for dissolution. 5.7 gm of L(+) tartaric acid was added to the solution, heated to about 50 C and stirred for about 30 minutes. The reaction mixture was cooled to 10-150C and stirred for 1 hour. The solid was filtered and washed with acetone (10 ml). The solid was dried 50-600C to obtain 12.5 gm of the title compound.
	In ethanol;Heating / reflux;	(iii) Synthesis of <strong>[123441-03-2]rivastigmin</strong>e hydrogentartrate An amount of 1.30 g (5.2 mmol) of 3-(1-(dimethylamino)ethyl)-phenyl ethyl(methyl)carbamate as obtained in step (i) and 2.10 g (5.2 mmol) of (+)-di-p-toluoyl-D-tartaric acid monohydrate were dissolved in 13 ml of methanol/water (2:1) solution under heating. The reaction mixture was refluxed for 1 hour and cooled to room temperature. The precipitate was filtered and four times recrystallized in a minimal volume of methanol/water solution to obtain optically pure di-p-toluoyl tartrate salt of (S)-3-(1-(dimethylamino)ethyl)phenyl ethyl-(methyl)carbamate. The salt was dissolved in 1 M NaOH and extracted into ether to obtain an optically pure oily residue of (S)-3-(1-(dimethylamino)ethyl)phenyl ethyl(methyl)carbamate which was dissolved in ethanol, mixed with hydrogentartrate, refluxed and cooled to room temperature.
	In acetone; at 4 - 60℃; for 19h;	2 g S-(-)-<strong>[123441-03-2]Rivastigmine</strong> and 1.2 g L-(+)-tartaric acid were added to 20 ml acetone and the mixture was heated at 600C for 1 hour to get a clear mixture. The solution was allowed to slowly cool to ambient temperature and was stirred for 18 hours at 4C until complete precipitation of the tartrate salt. The solid was isolated by filtration, washed with acetone, and dried for 22 hours under vacuum at 400C. Isolated yield: 2.72g, white solidXRPD pattern: comparable to Fig.l.
	In acetone; at 0 - 50℃; for 1.5h;	Example 7; Preparation of <strong>[123441-03-2]Rivastigmine</strong> hydrogentartrate salt170 ml of acetone was added to the above obtained residue and stirred for dissolution. 20.4 gm of L(+) tartaric acid was added to the solution, heated to about 50 C and stirred for about 30 minutes. The reaction mixture was cooled to 25-35 C and stirred for 30 minutes. The reaction mixture was further cooled to 0-5 C and stirred for 30 minutes. The solid was filtered and washed with acetone (20 ml). The solid was dried at 50-60C to obtain 46 gm of the title compound.Purity by HPLC: 99.84 %
2.5 g	In acetone; at 60℃; for 1h;	Example-9: Preparation of <strong>[123441-03-2]Rivastigmine</strong> Tartrate To a 250 ml. RB flask, <strong>[123441-03-2]Rivastigmine</strong> base (2.5 g), acetone (87.5 ml) and L-(+)-tartaric acid (1.5 g) were added. Heated the reaction mass at 60 C. for 1 hour and gradually cooled to room temperature. Filtered the reaction mass through hyflow bed and washed with acetone (12 ml). Evaporated half of the acetone volume and stirred at room temperature for 1 hour. Filtered the solid, washed with acetone and dried under vacuum to obtained 2.5 g of <strong>[123441-03-2]Rivastigmine</strong> Tartrate (Yield: 62.6%, HPLC: 99.48%, Chiral HPLC: 99.56%).

Reference： [1]Patent: WO2008/20452,2008,A1 .Location in patent: Page/Page column 10
[2]Patent: US2008/45743,2008,A1 .Location in patent: Page/Page column 5
[3]Patent: CN105439906,2016,A .Location in patent: Paragraph 0016
[4]Letters in Organic Chemistry,2010,vol. 7,p. 149 - 154
[5]Patent: WO2006/48720,2006,A1 .Location in patent: Page/Page column 12-13
[6]Synthetic Communications,2009,vol. 39,p. 1527 - 1533
[7]Patent: US2014/73809,2014,A1 .Location in patent: Paragraph 0076-0080
[8]Patent: EP2711354,2014,A1 .Location in patent: Paragraph 0049
[9]Patent: CN106565543,2017,A .Location in patent: Paragraph 0088; 0089; 0090
[10]Patent: EP2233465,2010,A1 .Location in patent: Page/Page column 9
[11]Patent: WO2005/61446,2005,A2 .Location in patent: Page/Page column 17
[12]Patent: WO2018/158674,2018,A1 .Location in patent: Page/Page column 13; 14
[13]Synthetic Communications,2012,vol. 42,p. 589 - 598
[14]Patent: WO2006/68386,2006,A1 .Location in patent: Page/Page column 6
[15]Patent: EP1980552,2008,A2 .Location in patent: Page/Page column 11
[16]Patent: US2008/255383,2008,A1 .Location in patent: Page/Page column 7
[17]Patent: US2008/306280,2008,A1 .Location in patent: Page/Page column 4-5
[18]Patent: WO2009/147687,2009,A2 .Location in patent: Page/Page column 17
[19]Patent: EP1942100,2008,A1 .Location in patent: Page/Page column 11
[20]Patent: WO2008/110339,2008,A2 .Location in patent: Page/Page column 10
[21]Journal of Organic Chemistry,2010,vol. 75,p. 3105 - 3108
[22]Patent: WO2011/70585,2011,A1 .Location in patent: Page/Page column 13
[23]Patent: US2020/95195,2020,A1 .Location in patent: Paragraph 0076

9
[ 727418-36-2 ]
[ 123441-03-2 ]

Yield	Reaction Conditions	Operation in experiment
66.3%	With sodium hydroxide; In water; for 0.5h;	[58] (S)-3-(l-dimethylaminoethyl)phenol hydrochloride (hydrochloride of the compound of Formula 8, 30 g, 0.148 mol) was suspended in acetonitrile (150 ml), and then N-ethyl-N-methylcarbamoyl chloride (36.1 g, 0.297 mol) was added thereto. The resulting solution was cooled to 0C. To the solution was added sodium hydride (29.7 g, 60%, 0.743 mol). The temperature was gradually allowed to rise to room temperature. The reaction mixture was stirred at room temperature for 24 hours. The completion of the reaction was confirmed by HPLC. The reaction mixture was extracted with ether, and organic layer was concentrated. Water and hydrochloric acid were added thereto. After the resulting mixture was stirred at room temperature for 2 hours, it was washed twice with ether. The obtained aqueous layer was concentrated and crystallized from ethylacetate, affording (S)-rivastigmine hydrochloride (22.28g, 52%). The (S)-rivastigmine hydrochloride (18.5 g, 64.5 mmol) was dissolved in water (60 ml), and then NaOH (2.58 g, 64.5 mmol, 1 eq.) was added thereto. The reaction mixture was stirred for 30 minutes. The mixture was extracted twice with ether, dried over anhydrous MgSO 4 , and concentrated under reduced pressure. The concentrate was distilled under vacuum at 116-128C to obtain rivastigmine (10.7 g, 66.3%) as a pure distillate. To the distillate were sequentially added acetone (30 ml) and L-tartaric acid (6 g, 40 mmol, 1 eq.). The mixture was refluxed for one hour, cooled to 00C, and filtered to obtain a solid. The solid was washed, and dried to afford (S)-rivastigmine tartrate salt*2 (16 g, 93.5% from the rivastigmine hydrochloride, 99.8% ee).[59] In addition, the same results were obtained when(S)-3-(l-dimethylaminoethyl)phenol (Formula 8, Example 2) in the free-base form was used instead of (S)-3-(l-dimethylaminoethyl)phenol hydrochloride (hydrochloride salt of the compound of Formula 8).[60] n : (S)-rivastigmine[61] ' H NuMR (CDCl3): 7.29 (IH, m), 7.01 (3H, m), 3.44 (2H, q), 3.24 (IH, q), 3.02(3H, d), 2.20 (6H, s), 1.35 (3H, d), 1.21 (3H, m)

Reference： [1]Patent: WO2006/68386,2006,A1 .Location in patent: Page/Page column 6

10
[ 42252-34-6 ]
[ 139306-10-8 ]
[ 123441-03-2 ]

Yield	Reaction Conditions	Operation in experiment
80.5%		Reference Example 1Preparation of S-(-)-Rivastigmine300 ml of tetrahydrofuran (THF) are placed in a 0.51-three-neck flask and sodium hydride as a 60% dispersion in oil (11.3 g) is added slowly under inert conditions (Ar or N2) and stirring. A suspension develops, to which alpha-m-hydroxy phenylethyldimethylamine (46.5 g, 0.281 mol) is added at room temperature. A solution of the phenolate forms, to which 35.7 g (0.281 mol) of carbamoylchloride are added dropwise over 10 minutes while slightly cooling down to 15 C. The reaction is slightly exothermic. The rate of dropping is kept such that the temperature of the reaction mixture does not exceed 30 C. After all the agent is added, the cooling system is put aside and the reaction mixture is mixed for 2 hours at room temperature. Thereafter, THF is evaporated in a rotary vacuum evaporator. The evaporation residue is partitioned between 200 ml IN NaOH and 500 ml of ether. The organic layer is separated and the aqueous fraction is shaken with additional 2×200 ml of ether. The combined ether layers are shaken out with 1×100 ml water and 1×50 ml brine. The organic fraction is dried over anhydrous sodium sulfate. The solvent is evaporated and the crude product is vacuum distilled.b.p.=135-140 C. at 13 Pa45.6 g of a colorless viscous oil are obtained, i.e. a 80.5% yield. Content GC 99.6%
74%	With potassium carbonate; In acetonitrile;	(S)-3-(l-dimethylaminoethyl) phenol (V-a; 25gm; 0.15mole) was reacted with Ethyl methyl carbamoyl chloride (20gm, 0.165 mole) in presence of anhydrous.potassium carbonate (31.5 gm, 0.228 moles) and acetonitrile (250ml) and heated. After completion of reaction the reaction mixture was filtered and the filtrate concentrated to give product. The product was optionally purified by acid base treatment. Yield: 27 gmYield: 74%Purity: 99% (by HPLC)
	With pyridine;tetrabutylammomium bromide; In 4-methyl-2-pentanone; at 30℃; for 15.75h;	EXAMPLE 5: PREPARATION OF (S)-N-ETHYL-N-METHYL-3-[1-DIMETHYL-AMINO)-ETHYL]-PHENYL CARBAMATE (FORMULA II); . 6 kg of S-(-)-[1-(3-hydroxyphenyl) ethyl] dimethyl amine of Formula III and 12 L of Methyl Isobutyl Ketone(MIBK) were charged and stirred for about 10 minutes. To this reaction solution 3.44 kg of pyridine, 1.18 kg of tetrabutylammonium bromide were charged and stirred for about 15 minutes to form clear solution. 3.97 kg of N-ethyl, N-methyl carbomyl chloride was added to the reaction mixture for about 30 minutes. Heated the contents to about 30C and stirred for about 15 hours. After completion of the reaction 48 lit of water was charged and pH was adjusted to about 1.5 using 3.72 lit of 36% aqueous hydrochloric acid. Stirred the contents for about 30 minutes at about 25C and aqueous layer was separated. The aqueous layers were then washed with MIBK (2x12 lit) and separate the aqueous layer. Aqueous layer pH was adjusted to 12.5 using 6 lit of 40% aqueous sodium hydroxide solution and stirred for about 15 minutes. The aqueous layer was then extracted with MIBK (2x12 lit) and separated the organic layer. Washed the organic layer with water (2x12 lit) and separated the organic layer. The obtained organic layer was distilled off completely at about 60C to afford residue. To the obtained residue 48 lit of ethyl acetate was added and pH of the reaction solution was adjusted to about 2 by adding about 6 lit of f 18% hydrochloride in isopropyl alcohol at about 5C and stirred for about 90 minutes for solid separation. The separated solid was filtered and washed with 6 lit of ethyl acetate. The obtained wet solid was again charged into a reaction containing 30 lit of water and adjusted the pH to about 12.5 using 1.8 lit of 40% aqueous sodium hydroxide solution(caustic lye). The reaction mass was extracted with MIBK (2x12 lit) and the combined organic layer was washed with water (2x12 lit). The organic layer was distilled completely at about 60C to afford residue. To the obtained residue 48 lit of ethyl acetate was added and pH of the reaction solution was adjusted to about 2 by adding about 6 lit of f 18% hydrochloride in isopropyl alcohol at about 5C and stirred for about 90 minutes for solid separation. The separated solid was filtered and washed with 6 lit of ethyl acetate. The obtained wet solid was again charged into a reaction containing 30 lit of water and adjusted the pH to about 12.5 using 1.8 lit of 40% aqueous sodium hydroxide solution. The reaction mass was extracted with MIBK (2x12 lit) and the combined organic layer was washed with water (2x121it). The organic layer was distilled completely at about 60C to afford the title compound Purity by HPLC. 99.33%

	With pyridine;tetrabutylammomium bromide; In 4-methyl-2-pentanone; at 30℃; for 15.75h;	Example 5; Preparation of (S)-N-Ethyl-N-Methyl-3-[1-Dimethyl-Amino)-Ethyl]-Phenyl Carbamate (Formula II); 6 kg of S- (-)-[1-(3-hydroxyphenyl)ethyl] dimethyl amine of Formula III and 12 L of Methyl Isobutyl Ketone(MIBK) were charged and stirred for about 10 minutes. To this reaction solution 3.44 kg of pyridine, 1.18 kg of tetrabutylammonium bromide were charged and stirred for about 15 minutes to form clear solution. 3.97 kg of N-ethyl, N-methyl carbornyl chloride was added to the reaction mixture for about 30 minutes. Heated the contents to about 30 C. and stirred for about 15 hours. After completion of the reaction 48 lit of water was charged and pH was adjusted to about 1.5 using 3.72 lit of 36% aqueous hydrochloric acid. Stirred the contents for about 30 minutes at about 25 C. and aqueous layer was separated. The aqueous layers were then washed with MIBK (2×12 lit) and separate the aqueous layer. Aqueous layer pH was adjusted to 12.5 using 6 lit of 40% aqueous sodium hydroxide solution and stirred for about 15 minutes. The aqueous layer was then extracted with MIBK (2×12 lit) and separated the organic layer. Washed the organic layer with water (2×12 lit) and separated the organic layer. The obtained organic layer was distilled off completely at about 60 C. to afford residue.To the obtained residue 48 lit of ethyl acetate was added and pH of the reaction solution was adjusted to about 2 by adding about 6 lit of 18% hydrochloride in isopropyl alcohol at about 5 C. and stirred for about 90 minutes for solid separation. The separated solid was filtered and washed with 6 lit of ethyl acetate. The obtained wet solid was again charged into a reaction containing 30 lit of water and adjusted the pH to about 12.5 using 1.8 lit of 40% aqueous sodium hydroxide solution (caustic lye). The reaction mass was extracted with MIBK (2×12 lit) and the combined organic layer was washed with water (2×12 lit). The organic layer was distilled completely at about 60 C. to afford residue.To the obtained residue 48 lit of ethyl acetate was added and pH of the reaction solution was adjusted to about 2 by adding about 6 lit of 18% hydrochloride in isopropyl alcohol at about 5 C. and stirred for about 90 minutes for solid separation. The separated solid was filtered and washed with 6 lit of ethyl acetate. The obtained wet solid was again charged into a reaction containing 30 lit of water and adjusted the pH to about 12.5 using 1.8 lit of 40% aqueous sodium hydroxide solution. The reaction mass was extracted with MIBK (2×12 lit) and the combined organic layer was washed with water (2×12 lit). The organic layer was distilled completely at about 60 C. to afford the title compound.Purity by HPLC. 99.33%
		Example 6; Preparation of Rivastigmine25 gm of S-(-)-3-[(l-dimethylamino) ethylj-phenol was dissolved in 250 ml of THF and 12.5 gm of KOH was charged in a flask and stirred for 10 minutes. The reaction mixture was cooled to 10-15C under nitrogen atmosphere. 25 gm of N-methyl, N-ethyl carbamoyl chloride was added slowly for about 30 minutes and then stirred for 30 minutes. The reaction mixture temperature was allowed to 25-35 and stirred for about 5 hours. The reaction mixture was charged into a flask containing 200 ml of water which is cooled to 0-5C. The reaction mixture was extracted with toluene (200 ml). Total organic layer was extracted with 20 % aqueous HCl solution. The aqueous layer pH was adjusted to about 10 using aqueous sodium hydroxide solution. The aqueous layer was extracted with dichloromethane (200 ml). The total dichloromethane layer was washed with water and distilled off completely to get 34 gm of rivastigmine base.
77.1 g	With sodium hydride; In tetrahydrofuran; at 0 - 20℃; for 3h;	2L of tetrahydrofuran was added to the reaction flask, and 100 g of Intermediate 1 was dissolved with stirring. The ice-water bath was cooled to 13 C. and 30 g of sodium hydride was slowly added in portions. After the addition is completed, it is cooled to 0C. A solution of 80 g of N-ethyl-N-methylcarbamoyl chloride in tetrahydrofuran (80 g of N-ethyl-N-methylcarbamoyl chloride dissolved in 160 ml of tetrahydrofuran) was added dropwise, and the mixture was naturally heated toAt room temperature, the reaction was stopped for 3 hours. After the reaction was completed, 100 ml of water was slowly added to quench the reaction. The tetrahydrofuran was concentrated under reduced pressure, 800 ml of water was added to the system, pH was adjusted to 3.5 with concentrated hydrochloric acid, and dichloromethane (500 ml) was washed with 33. The organic layer was discarded. The aqueous phase was extracted with 2M NaOH solution adjusted to pH 11,600 ml2 dichloromethane and the aqueous phase was discarded. The methylene chloride layer was washed once with 1 M sodium hydroxide solution, twice with water, and once with saturated brine. The dichloride layer was collected and concentrated to obtain 77.1 g of a pale yellow oil.

Reference： [1]Angewandte Chemie - International Edition,2015,vol. 54,p. 11852 - 11856
Angew. Chem.,2015,vol. 127,p. 12019 - 12023,5
[2]Organic and Biomolecular Chemistry,2019,vol. 17,p. 7651 - 7654
[3]Organic Process Research and Development,2013,vol. 17,p. 307 - 312
[4]Journal of Organic Chemistry,2009,vol. 74,p. 5304 - 5310
[5]Patent: US2008/45743,2008,A1 .Location in patent: Page/Page column 5
[6]Patent: WO2006/48720,2006,A1 .Location in patent: Page/Page column 4; 12
[7]Patent: EP1980552,2008,A2 .Location in patent: Page/Page column 11
[8]Patent: US2008/255383,2008,A1 .Location in patent: Page/Page column 7
[9]Chemical Communications,2010,vol. 46,p. 5500 - 5502
[10]Patent: WO2011/70585,2011,A1 .Location in patent: Page/Page column 13
[11]Patent: CN106565543,2017,A .Location in patent: Paragraph 0085; 0086; 0087; 0097; 0098; 0099; 0108-0110
[12]Chemistry Letters,2019,vol. 48,p. 1065 - 1068

11
[ 399515-02-7 ]
[ 123441-03-2 ]

Yield	Reaction Conditions	Operation in experiment
	With ammonia; In water;pH 11;	Example 2: Preparation Rivastigmine Hydrogentartarate salt22 gm of the Rivastigmine (+) DPTTA salt obtained as 2nd crop in Example 1 Step (c) was charged in a flask containing 150 ml of water and pH was adjusted to about 11 using about 20 ml of aqueous ammonia. The reaction mixture was extracted with dichloromethane(DCM) (250 ml) and the organic layer was washed with water (100 ml). The final organic layer was distilled completely to obtain 9.5 gm of Rivastigmine base as residue.25 ml of acetone was added to the above obtained residue and stirred for dissolution. 5.7 gm of L(+) tartaric acid was added to the solution, heated to about 50 C and stirred for about 30 minutes. The reaction mixture was cooled to 10-150C and stirred for 1 hour. The solid was filtered and washed with acetone (10 ml). The solid was dried 50-600C to obtain 12.5 gm of the title compound.
	With sodium hydroxide; water;	(iii) Synthesis of rivastigmine hydrogentartrate An amount of 1.30 g (5.2 mmol) of 3-(1-(dimethylamino)ethyl)-phenyl ethyl(methyl)carbamate as obtained in step (i) and 2.10 g (5.2 mmol) of (+)-di-p-toluoyl-D-tartaric acid monohydrate were dissolved in 13 ml of methanol/water (2:1) solution under heating. The reaction mixture was refluxed for 1 hour and cooled to room temperature. The precipitate was filtered and four times recrystallized in a minimal volume of methanol/water solution to obtain optically pure di-p-toluoyl tartrate salt of (S)-3-(1-(dimethylamino)ethyl)phenyl ethyl-(methyl)carbamate. The salt was dissolved in 1 M NaOH and extracted into ether to obtain an optically pure oily residue of (S)-3-(1-(dimethylamino)ethyl)phenyl ethyl(methyl)carbamate which was dissolved in ethanol, mixed with hydrogentartrate, refluxed and cooled to room temperature.
	Alkaline aqueous solution;	The resolution of racemic compound (10gm) with (+)-O, O'-ditoluyltartaric acid (16gm) in methanol (20ml) and water (10ml) gave 6 gm of desired isomer under cold condition. The pure isomer was obtained after crystallization (thrice) in mixture of water and methanol (1:2). The tartrate salt (6 gm) was treated with caustic solution, extracted with dichloromethane and concentrated in vacuum to yield 2 gm of pale yellow oil. Yield: 20-25gms. %Yield: 20%(w/w). HPLC Purity: 99%.

Reference： [1]Patent: WO2009/147687,2009,A2 .Location in patent: Page/Page column 17
[2]Patent: EP1942100,2008,A1 .Location in patent: Page/Page column 11
[3]Patent: WO2006/48720,2006,A1 .Location in patent: Page/Page column 4; 11

12
[ 50-00-0 ]
[ 923035-05-6 ]
[ 141-53-7 ]
[ 123441-03-2 ]

Yield	Reaction Conditions	Operation in experiment
		Example 8; Obtaining (S)-N-ethyl-3-[1-(dimethylamino)ethyl]-N-methylphenylcarbamate [Rivastigmine] 2.5 mL of 98% formic acid, 0.4 g of sodium formiate and 1 mL of 37% formaldehyde aqueous solution are added to 0.5 g of the compound of formula (II) [Example 7]. The mixture is heated under reflux and maintained at this temperature until the end of the reaction. It is processed by adding 5 mL of methylene chloride and the mixture is adjusted to pH 8.7. The separated organic phase is distilled until obtaining a residue that is purified by column chromatography and is identified as the desired product. 1H NMR: delta 1.15-1.2 (2t, 3H, N-CH2-CH3) ; delta 1.3 (d, 3H, -CH-CH3) ; delta 2.2 (s, 6H, N-CH3); delta 2.96-3.04 (2s, 3H, OCN-CH3); 3.2 (q, 1H, -CH-CH3) ; delta 3.36-3. 44 (2*q, 2H, N-CH2-CH3) ; delta 6.96 (d, 1H, Ar-H); delta 7.05 (s, 1H, Ar-H); delta 7.10 (d, 1H, Ar-H); delta 7.3 (t, 1H, Ar-H)

Reference： [1]Patent: EP1939172,2008,A2 .Location in patent: Page/Page column 15

13
[ 50-00-0 ]
[ 923035-05-6 ]
[ 123441-03-2 ]

Yield	Reaction Conditions	Operation in experiment
79.3%		Example 9: Preparation of N-methylethylcarbamino-3-[(S)-1-(dimethylamino) ethyl] phenyl ester (the compound represented by formula (VII)); 11.27g (39.2mmol) the compound represented by formula (VI) obtained in Example 4 and 7.22g (157mmol) formic acid were mixed at room temperature, and then 6.54g (78.4mmol) formaldehyde aqueous solution (37mass%) was added. The mixture was fluxed for 2 hours, and then cooled to room temperature. 50ml water was added, followed by adding sodium carbonate in batches to adjust pH to 8. The result was then extracted with 60ml ethyl acetate twice. The combined organic layers was washed with 15ml water, and then dried with anhydrous magnesium sulfate. Colorless liquid (11.3g) was obtained after filtering and recovering the solvent under a reduced pressure. Vacuum distillation: 1 to 1.5 kpa, the fraction at a temperature ranging from 128C to 133C is collected, and 7.77g product is obtained with a yield of 79.3%. Optical rotation [alpha]20D = -32.1, C=5, ethanol. 1H NMR (CDCl3) delta ppm: 1.22 (m, 3H), 1.35 (q, 3H), 2.20 (s, 6H), 3.02 (d, 3H), 3.25 (m, 1H), 3.44 (s, 2H), 7.05 (m, 3H), 7.27 (m, 1H); MS (ESI) m/z: 251.2(M++1).
		Example 5; Obtaining (S)-N-ethyl-3-[1-(dimethylamino)ethyl]-N-methylphenylcarbamate [Rivastigmine] 1 g of the oil obtained in Example 4 is dissolved in 10 mL of methanol and 1.4 mL of acetic acid, cooling the mixture between 0C and -5 C. 0.32 g of sodium cyanoborohydride are added to this mixture, maintaining the temperature under 0C. Once the addition has been completed, 0.53 mL of a 37% formaldehyde aqueous solution in 10 mL of methanol are added and it is maintained stirring at room temperature until the end of the reaction. Then 10 mL of a 10% hydrochloric acid aqueous solution are added, the methanol residues are distilled at reduced pressure and extracted with 10 mL of methylene chloride. 20 mL of methylene chloride are added to the separated aqueous phase and the mixture is adjusted to pH 8.7 with sodium hydroxide aqueous solution. The separated organic phase is distilled at reduced pressure until obtaining a yellow oil weighing 0.8 g, and which is identified as the desired product. 1H NMR: delta 1.15-1.2 (2t, 3H, N-CH2-CH3) ; delta 1.3 (d, 3H, -CH-CH3) ; delta 2.2 (s, 6H, N-CH3); delta 2.96- 3.04 (2s, 3H, OCN-CH3); 3.2 (q, 1H, -CH-CH3) ; delta 3.36-3. 44 (2*q, 2H, N-CH2-CH3) ; delta 6.96 (d, 1H, Ar-H); delta 7.05 (s, 1H, Ar-H); delta 7.10 (d, 1H, Ar-H); delta 7.3 (t, 1H, Ar-H)

Reference： [1]Patent: EP2233465,2010,A1 .Location in patent: Page/Page column 9
[2]Synthetic Communications,2009,vol. 39,p. 1527 - 1533
[3]Patent: EP1939172,2008,A2 .Location in patent: Page/Page column 14

14
1-[(N-ethyl-(N-methyl)amino)carbonyl]-3-methyl-1H-imidazolium iodide [ No CAS ]
[ 139306-10-8 ]
[ 123441-03-2 ]

Yield	Reaction Conditions	Operation in experiment
		EXAMPLE 4 Preparation of (S)-N-Ethyl-N-methyl-3-[1-(dimethylamino)ethyl]-phenyl carbamate from (S)-3-[1-(Dimethylamino)ethyl]phenol and 1-[(N-ethyl-methylamino)carbonyl]-3-methyl-1H-imidazolium iodide Triethylamine (14.7 g, 145.2 mmol) and 1-[[N-ethyl-(N-methyl)amino]carbonyl}-3-methyl-1H-imidazolium iodide (42.9 g, 145.25 mmol) were added slowly to the cooled solution of (S)-3-[1-(dimethylamino)ethyl]phenol (20 g, 121.0 mmol) in acetonitirile (60 mL). The reaction mixture was stirred at 75-80 C. until reaction completion as determined by 1H NMR. The reaction mixture was evaporated and the obtained residue was diluted with water (40 mL) and toluene (60 mL) and then basified with 50% aq. NaOH solution at <10 C. The phases were separated and the aqueous phase was extracted with toluene. The combined organic phases were washed with water. The organic solution was evaporated under vacuum to give (S)-N-ethyl-N-methyl-3-[1-(dimethylamino)ethyl]phenyl carbamate (Rivastigmine free base). 1H-NMR (CDCl3) delta 7.29 (t, J=7.80 Hz, 1H); 7.13-6.90 (m, 3H); 3.50-3.35 (m, 2H); 3.24 (q, J=6.7 Hz, 1H); 3.02 (ad, 3H); 2.20 (s, 6H); 1.36 (d, J=6.7 Hz, 3H); 1.26-1.15 (m, 3H).

Reference： [1]Patent: US2008/306280,2008,A1 .Location in patent: Page/Page column 4

15
1-[[N-ethyl-(N-methyl)amino]carbonyl]-3-methyl-1H-imidazolium methyl sulfate [ No CAS ]
[ 139306-10-8 ]
[ 123441-03-2 ]

Yield	Reaction Conditions	Operation in experiment
		EXAMPLE 7 Preparation of (S)-N-Ethyl-N-methyl-3-[1-(dimethylamino)ethyl]-phenyl carbamate (2R,3R)-hydrogen tartrate from (S)-3-[1-(Dimethylamino)ethyl]phenol and 1-[(N-ethyl-methylamino)carbonyl]-3-methyl-1H-imidazolium methyl sulfate Triethylamine (3.6 g, 35.4 mmol) and 1-{([N-ethyl-(N-methyl)amino]carbonyl}-3-methyl-1H-imidazolium methyl sulfate (9.1 g, 32.6 mmol) were added slowly to the cooled solution of (S)-3-[1-(dimethylamino)ethyl]phenol (4.5 g, 27.23 mmol) in acetonitirile (25 mL). The reaction mixture was stirred at 75-80 C. until reaction completion as determined by 1H NMR. The reaction mixture was evaporated and the obtained residue was diluted with water (30 mL) and toluene (30 mL) and then basified with 50% aq. NaOH solution at internal temperature below 10 C. The phases were separated and the aqueous phase was extracted with toluene. The combined organic phases were washed with water. The organic solution was evaporated under vacuum to give (S)-N-ethyl-N-methyl-3-[1-(dimethylamino)ethyl]phenyl carbamate. The residue dissolved in isopropanol (45 mL) and to the solution was added (2R,3R)-tartaric acid (4.08 g, 27.23 mmol) and heated to 70-80 C. The solution was cooled and the resulting suspension was filtered and dried to give (S)-N-Ethyl-N-methyl-3-[1-(dimethylamino)ethyl]-phenyl carbamate (2R,3R)-hydrogen tartrate (8.54 g, 78% yield). The 1H NMR spectrum of the product was identical to that of example 6.

Reference： [1]Patent: US2008/306280,2008,A1 .Location in patent: Page/Page column 4-5

16
(S)-3-[1-(dimethylamino)ethyl]phenol (1S)-10-camphorsulfonate [ No CAS ]
1-[(N-ethyl-(N-methyl)amino)carbonyl]-3-methyl-1H-imidazolium iodide [ No CAS ]
[ 123441-03-2 ]

Yield	Reaction Conditions	Operation in experiment
		EXAMPLE 5 Preparation of (S)-N-Ethyl-N-methyl-3-[1-(dimethylamino)ethyl]-phenyl carbamate from (S)-3-[1-(Dimethylamino)ethyl]phenol (1S)-10-Camphorsulfonate Triethylamine (12.7 g, 125.8 mmol) was added slowly to a solution of (S)-3-[1-(dimethylamino)ethyl]phenol (1S)-10-camphorsulfonate (20 g, 50.3 mmol) in acetonitirile (60 mL) while keeping the internal temperature below 10 C. The reaction mixture was stirred for 0.5-1 hour. A solution of 1-[[N-ethyl-(N-methyl)amino]carbonyl]-3-methyl-1H-imidazolium iodide (14.3 g, 55.3 mmol) was then added slowly while keeping the internal temperature below 10 C. The reaction mixture was warmed to 75-80 C. and maintained until reaction completion as determined by 1H NMR. The reaction mixture was evaporated and the obtained residue was diluted with water (40 mL) and toluene (60 mL) and subsequently basified with 50% aq NaOH solution at internal temperature below 10 C. The phases were separated and the aqueous phase was extracted with toluene. The combined organic phases were washed with water. The organic solution was evaporated under vacuum to give (S)-N-ethyl-N-methyl-3-[1-(dimethylamino)ethyl]-phenyl carbamate (Rivastigmine free base) (12.5 g). The 1H NMR spectrum of the product was identical to that of example 4.

Reference： [1]Patent: US2008/306280,2008,A1 .Location in patent: Page/Page column 4

Yield	Reaction Conditions	Operation in experiment
		a compound for the treatment of Alzheimer's disease, in particular: an anticholinesterase, such as: donepezil, galantamine, rivastigmine,

18
[ 856408-80-5 ]
[ 124-40-3 ]
[ 123441-03-2 ]

Yield	Reaction Conditions	Operation in experiment
87%		Stage 3; Materials :- Mw Mass, g mMole Mole Ratio s Alcohol substrate from Stage 2 223 3.40 15.25 1.0 Triethylamine 101. 1 4.60 45. 75 3.0 Methane sulphonic Anhydride 174. 2 3.45 19.8 1. 3 Dimethylamine 45. 05 91. 5 6 THF 70mL Method:- The alcohol obtained in stage 2, without further purification, (3.40g, 15. 25mmol) was dissolved in dry THF (40ml) and cooled in an ice-water bath. Then, triethylamine (4.60g, 45. 75mmol) was added and the solution kept cooled. Methanesulfonic anhydride (3.45g, 19. 8mmol) was dissolved in dry THF (30ml) and added to the cold reaction mixture dropwise over 30 minutes. The reaction mixture was stirred at 0C for 2 hours until conversion was 100% (GC) and then dimethylamine (46mol, 2M solution in THF) was added and the reaction mixture allowed to reach room temperature. After 48 h stirring conversion was 70% (GC), additional dimethylamine (46mmol) was then added and 24 hours later the conversion achieved was 99%. The reaction mixture was poured into 1M HCl (aq) (350ml) and extracted with dichloromethane (350ml), the organic layer was extracted again with 1M HC) (aq) (200m .) and both aqueous layers were combined and neutralized with 2M NaOH (aq) until the pH was above 10, then extracted with dichloromethane (3x350ml), the organic layers combined, dried and the solvent distilled to obtain 3.34g (87%) of the final product as a reddish oil. The specific optical rotation of the product was measured at-31 (3% solution in MeOH) (lit. Rivastigmine-32, Helv. Chim. Acta, 73 (3), 1990,739-753).

Reference： [1]Patent: WO2005/58804,2005,A1 .Location in patent: Page/Page column 18-19

19
[ 87-69-4 ]
[ 42252-34-6 ]
[ 139306-10-8 ]
[ 123441-03-2 ]

Yield	Reaction Conditions	Operation in experiment
		Example 7; Preparation of CffH-VRivastigmine Tartrate; To a solution of lOOg of (S)-[I -(3 -hydroxyphenyl) ethyl] dimethylamine (VIII) in 500ml of acetone, pulverized potassium carbonate (125.2g) was added. The reaction mixture was heated to 40-450C for 1 hour. A solution of iV-ethyl-iV-methylcarbamoyl chloride (77.5 g) in acetone (300ml) was added to the reaction mixture and the temperature of the reaction mixture was raised to 55-600C followed by stirring at the same temperature for 8-10 hours. After the completion of the reaction, the reaction mixture was cooled and filtered. The solvent was then removed under reduced pressure, water (500ml) and toluene (300ml) were added followed by pH adjustment to 1 -2 using concentrated hydrochloric acid. After separating the organic layer, ethyl acetate (500ml) was added to the aqueous layer and pH was adjusted to 9-11 with liquid ammonia. The organic layer was separated and concentrated under reduced pressure to obtain oil. To this oily mass, acetone (750ml) and activated charcoal (5g) were added and stirred for 30 minutes. The reaction mixture was then filtered first through hyflo bed and then through micron filter. (L)-(+)-Tartaric acid was added to the filtrate and the reaction mixture was stirred for 4-5 hours and filtered. The solid thus obtained was washed with acetone and dried to obtain the title compound as solid
		Example 7 Preparation of (S)-(-)-Rivastigmine Tartrate To a solution of 100 g of (S)-[1-(3-hydroxyphenyl)ethyl]dimethylamine (VIII) in 500 ml of acetone, pulverized potassium carbonate (125.2 g) was added. The reaction mixture was heated to 40-45 C. for 1 hour. A solution of N-ethyl-N-methylcarbamoyl chloride (77.5 g) in acetone (300 ml) was added to the reaction mixture and the temperature of the reaction mixture was raised to 55-60 C. followed by stirring at the same temperature for 8-10 hours. After the completion of the reaction, the reaction mixture was cooled and filtered. The solvent was then removed under reduced pressure, water (500 ml) and toluene (300 ml) were added followed by pH adjustment to 1-2 using concentrated hydrochloric acid. After separating the organic layer, ethyl acetate (500 ml) was added to the aqueous layer and pH was adjusted to 9-11 with liquid ammonia. The organic layer was separated and concentrated under reduced pressure to obtain oil. To this oily mass, acetone (750 ml) and activated charcoal (5 g) were added and stirred for 30 minutes. The reaction mixture was then filtered first through hyflo bed and then through micron filter. (L)-(+)-Tartaric acid was added to the filtrate and the reaction mixture was stirred for 4-5 hours and filtered. The solid thus obtained was washed with acetone and dried to obtain the title compound as solid

Reference： [1]Patent: WO2010/23535,2010,A1 .Location in patent: Page/Page column 14
[2]Patent: US2012/22281,2012,A1 .Location in patent: Page/Page column 5

20
[ 123441-03-2 ]
[ 139306-10-8 ]

Reference： [1]Journal of Medicinal Chemistry,2010,vol. 53,p. 1190 - 1199

21
[ 139306-10-8 ]
[ 51493-02-8 ]
[ 123441-03-2 ]

Reference： [1]Letters in Organic Chemistry,2010,vol. 7,p. 149 - 154

22
[ 1418318-99-6 ]
[ 124-40-3 ]
[ 123441-03-2 ]

Reference： [1]Journal of Organic Chemistry,2010,vol. 75,p. 3105 - 3108
[2]Organic Process Research and Development,2013,vol. 17,p. 307 - 312

23
[ 123441-03-2 ]
[ 624-78-2 ]
[ 124-38-9 ]
[ 139306-10-8 ]

Reference： [1]Bioorganic and Medicinal Chemistry Letters,2009,vol. 19,p. 3243 - 3246

24
[ 624-78-2 ]
[ 139306-10-8 ]
[ 530-62-1 ]
[ 123441-03-2 ]

Yield	Reaction Conditions	Operation in experiment
		A mixture of (S)-3-[1-(dimethylamino)ethyl]phenol (1.64 g, 10 mmoL) in acetonitrile (10 mL) was stirred under nitrogen at 0-5 C. 1,1'-Carbonyldiimidazole (2.2 g, 13.5 mmoL) was added to the mixture and the resulting solution was stirred at room temperature overnight. The solution was cooled using an ice-bath and acetic acid (0.82 g, 13.5 mmoL) was added followed by N-ethylmethylamine (1.13g, 15 mmoL). The solution was allowed to warm slowly to room temperature and stirred overnight. The reaction mixture was evaporated and the residue was dissolved in diethyl ether (30 mL). Water (20 mL) was added to the solution and the pH of the aqueous layer was adjusted to >10 by the addition of aqueous NaOH solution. The organic layer was separated and the aqueous layer was extracted with diethyl ether. The combined ethereal extracts were washed with water and evaporated to dryness to give (S)-Rivastigime (1.8 g) as a liquid with enantiomeric purity >99.0% (chiral HPLC).

Reference： [1]Patent: US2007/207990,2007,A1 .Location in patent: Page/Page column 3-4

25
[ 624-78-2 ]
[ 139306-10-8 ]
[ 7693-46-1 ]
[ 123441-03-2 ]

Yield	Reaction Conditions	Operation in experiment
		A solution of (S)-3-[1-(dimethylamino)ethyl]phenol (4.1 g, 25 mmoL) and triethylamine (8.0 g, 79 mmoL) in dichloromethane (40 mL) was stirred under nitrogen and cooled using an ice-bath. 4-Nitrophenyl chloroformate (6.0 g, 3 mmoL) was added to the solution and the mixture was stirred for 2 h whereupon N-ethylmethylamine (2.2 g, 37.5 mmoL) was added in portions and the solution was allowed to warm slowly to room temperature and stirred overnight. The reaction mixture was quenched by the addition of water (20 mL) and the pH of the aqueous layer was adjusted to >10 by the addition of aqueous NaOH solution. The organic layer was separated and the aqueous layer was extracted with additional dichloromethane. The combined extracts were washed with water and evaporated to dryness. The residue was dissolved in diethyl ether and extracted with dilute HCl solution. The pH of the aqueous solution was adjusted to >10 by the addition of aqueous NaOH and extracted with diethyl ether. The ethereal layers were washed with water and evaporated to dryness to give (S)-Rivastigime (4.2 g) as a liquid with enantiomeric purity >99.0% (chiral HPLC).

Reference： [1]Patent: US2007/207990,2007,A1 .Location in patent: Page/Page column 4

26
[ 1222073-99-5 ]
[ 124-40-3 ]
[ 123441-03-2 ]

Reference： [1]Beilstein Journal of Organic Chemistry,2010,vol. 6,p. 1174 - 1179

27
[ 50919-07-8 ]
[ 123441-03-2 ]

Reference： [1]Patent: WO2011/70585,2011,A1

28
[ 139306-10-8 ]
[ 123441-03-2 ]

Reference： [1]Patent: WO2011/70585,2011,A1
[2]Synthetic Communications,2012,vol. 42,p. 589 - 598

29
[ 198756-81-9 ]
[ 123441-03-2 ]

Reference： [1]Patent: WO2011/70585,2011,A1

30
[ 889443-69-0 ]
[ 123441-03-2 ]

Reference： [1]Patent: WO2011/70585,2011,A1
[2]Angewandte Chemie - International Edition,2015,vol. 54,p. 11852 - 11856
Angew. Chem.,2015,vol. 127,p. 12019 - 12023,5
[3]Organic and Biomolecular Chemistry,2019,vol. 17,p. 7651 - 7654
[4]Patent: US2020/95195,2020,A1

31
[ 1017234-23-9 ]
[ 123441-03-2 ]

Reference： [1]Synthetic Communications,2012,vol. 42,p. 589 - 598
[2]Patent: US2014/73809,2014,A1
[3]Patent: US2014/73809,2014,A1
[4]Patent: EP2711354,2014,A1
[5]Patent: EP2711354,2014,A1

32
C₁₆H₁₇NO [ No CAS ]
[ 123441-03-2 ]

Reference： [1]Synthetic Communications,2012,vol. 42,p. 589 - 598

33
C₅H₈Cl₃NO₂ [ No CAS ]
[ 139306-10-8 ]
[ 123441-03-2 ]

Reference： [1]Synthetic Communications,2012,vol. 42,p. 589 - 598

34
[ 1017234-21-7 ]
[ 123441-03-2 ]

Reference： [1]Synthetic Communications,2012,vol. 42,p. 589 - 598

35
[ 894079-42-6 ]
[ 123441-03-2 ]

Reference： [1]Synthetic Communications,2012,vol. 42,p. 589 - 598

36
[ 121-71-1 ]
[ 123441-03-2 ]

Reference： [1]Synthetic Communications,2012,vol. 42,p. 589 - 598
[2]Organic Process Research and Development,2013,vol. 17,p. 307 - 312
[3]Organic Process Research and Development,2013,vol. 17,p. 307 - 312
[4]Tetrahedron Asymmetry,2013,vol. 24,p. 374 - 379
[5]Patent: US2020/95195,2020,A1
[6]Patent: US2020/95195,2020,A1
[7]Patent: US2020/95195,2020,A1
[8]Patent: US2020/95195,2020,A1

37
[ 67-56-1 ]
[ 123441-03-2 ]
[ 1416014-88-4 ]

Reference： [1]Journal of Photochemistry and Photobiology A: Chemistry,2012,vol. 239,p. 1 - 6

38
[ 123441-03-2 ]
[ 855300-09-3 ]

Reference： [1]Journal of Photochemistry and Photobiology A: Chemistry,2012,vol. 239,p. 1 - 6

39
[ 123441-03-2 ]
[ 855300-09-3 ]
[ 1222073-98-4 ]

Reference： [1]Journal of Photochemistry and Photobiology A: Chemistry,2012,vol. 239,p. 1 - 6

40
[ 123441-03-2 ]
[ 1346602-84-3 ]
[ 1392101-35-7 ]

Reference： [1]Journal of Photochemistry and Photobiology A: Chemistry,2012,vol. 239,p. 1 - 6

41
[ 50-00-0 ]
[ 1176026-49-5 ]
[ 123441-03-2 ]

Yield	Reaction Conditions	Operation in experiment
> 99%	With sodium tris(acetoxy)borohydride; In dichloromethane; water; at 20℃; for 16.5h;	Amine (S)-4 (64 mg, 0.29 mmol) was dissolved in CH2Cl2 (6 mL) and Na2SO4 (42 mg, 0.30 mmol), NaBH(OAc)3 (504 mg, 2.4 mmol) and formaldehyde (37% in water, 88 muL, 1.0 mmol) were added and the reaction mixture was stirred at room temperature for 16.5 h. The reaction was quenched with satd K2CO3 solution. The phases were separated, the aqueous phase was washed with EtOAc (2×10 mL) and the combined organic phase was dried over Na2SO4, filtered and concentrated under reduced pressure to give (S)-1 (72 mg, 0.29 mmol, >99%): -32.8 (c 1.0, CH2Cl2), (lit. -28.5, c 1.0, CH2Cl2);5cupsilonmax 2974, 2934, 2817, 2768, 1716, 1607, 1589, 1454, 1435, 1396, 1227, 1156 cm-1; 1H NMR (DMSO) 7.30 (t, 1H, J=7.8), 7.12 (d, 1H, J=7.8), 7.02-6.96 (m, 2H), 3.45-3.23 (m, 3H), 3.01 (s, 1.5H, 1 rotamer), 2.89 (s, 1.5H, 1 rotamer), 2.09 (s, 6H), 1.26 (s, 1.5H, 1 rotamer), 1.24 (s. 1.5H, 1 rotamer), 1.15 (t, 1.5H, J=6.9, 1 rotamer), 1.10 (t, 1.5H, J=7.2, 1 rotamer); 13C NMR (DMSO) 154.1 (1 rotamer), 154.0 (1 rotamer), 151.7, 146.1, 129.2, 124.4, 121.0, 120.7, 64.8, 43.9, 43.0, 34.3 (1 rotamer), 34.0 (1 rotamer), 20.1, 13.6 (1 rotamer), 12.8 (1 rotamer); GC-EIMS: tret 12.65, m/z (relative intensity [%]): 2502 (5), 235 (100), 206 (2), 164 (2), 150 (5), 86 (18), 72 (35), 58 (18); HRMS (ESI): MH+ found 251.1752, C14H23N2O2+ requires 251.1760; chiral HPLC analysis {Daicel Chiracel OD-H, n-heptane/2-propanol/TFA 8/2/0.2, 0.8 mL/min, 25 C, UV 215 nm, tret[(R)-1]=10.5 min, tret[(S)-1=16.0 min]: tret=16.1 min, >99% ee.
91%	With sodium tris(acetoxy)borohydride; sodium sulfate; In dichloromethane; water; at -10℃; for 8h;	To a solution of compound 6 (64 mg, 0.29 mmol) in CH2Cl2 (6 mL), Na2SO4 (42 mg, 0.30 mmol),NaBH(OAc)3 (504 mg, 2.4 mmol) and formaldehyde (37% in water, 88 L, 1.0 mmol) were added subsequently. Then the reaction mixture was stirred at -10 C for 8 h. The reaction was quenched with aqueous K2CO3 solution. The phases were separated, the aqueous phase was extracted withEtOAc (20 mL 2) and the combined organic phase was dried over Na2SO4, filtered and concentrated under reduced pressure to give crude product, which was purified by flash column chromatography(DCM/MeOH = 20:1) to yield the desired (S)-Rivastigmine as oil (Yield: 91%, ee: 96%). []25D = 29.8(c = 1.0, EtOH) ([]29D = 32.8 (c = 1.3, EtOH))[16]. 1H-NMR (400 MHz, Chloroform-d): 7.31-7.27 (m,1H, ArH), 7.12 (d, J = 9.5 Hz, 1H, ArH), 7.06 (s, 1H, ArH), 7.02 (d, J = 10.0 Hz, 1H, ArH), 3.49-3.38 (m,2H, -CH2CH3), 3.27 (q, J = 8.5 Hz, J = 16.5 Hz, 1H, -CHCH3), 3.06 (d, J = 37 Hz, 3H, -NCH3), 2.22 (s,6H, -N(CH3)2), 1.37 (d, J = 8.5 Hz, 3H, -CHCH3), 1.25-1.17 (m, 3H, -CH2CH3); 13C-NMR (100 MHz,Chloroform-d): 153.59, 150.54, 144.72, 127.85, 123.20, 119.74, 64.62, 43.01, 42.18, 33.18, 19.04, 12.21.HRMS for C14H23N2O2: [M + H]+ m/z 251.17540, found m/z 251.17538.

Reference： [1]Tetrahedron,2012,vol. 68,p. 7691 - 7694
[2]Molecules,2018,vol. 23

42
[ 1233378-72-7 ]
[ 123441-03-2 ]

Reference： [1]Organic Process Research and Development,2013,vol. 17,p. 307 - 312

43
[ 1233378-78-3 ]
[ 123441-03-2 ]

Reference： [1]Organic Process Research and Development,2013,vol. 17,p. 307 - 312

44
(R)‐(+)‐3‐(1‐hydroxyethyl)phenol [ No CAS ]
[ 123441-03-2 ]

Reference： [1]Organic Process Research and Development,2013,vol. 17,p. 307 - 312

45
[ 855300-09-3 ]
[ 123441-03-2 ]

Reference： [1]Organic Process Research and Development,2013,vol. 17,p. 307 - 312
[2]Tetrahedron Asymmetry,2013,vol. 24,p. 374 - 379

46
C₁₂H₁₆BrNO₂ [ No CAS ]
[ 506-59-2 ]
[ 123441-03-2 ]

Yield	Reaction Conditions	Operation in experiment
85%		General procedure: At first, 41.5g of dimethyl amine hydrochloride in 50mL of methanol was taken and stirred for 60min at 0-5C. The reaction mass was neutralized using methanol/ sodium hydroxide (20g in 85mL methanol) and stirred for 60min at 0-5C. The reaction mixture was filtered under nitrogen. To the filtrate were added 10g of ethyl-methyl-carbamic acid-3-[(1R)-bromo-ethyl]-phenyl ester 3 in 10mL of methanol. The reaction mixture was then stirred at 25C for 5-7h. The progress of the reaction was monitored by TLC. After completion, the reaction mass was distilled off to remove methanol under reduced vacuum. The crude oil was acidified with 100mL of 10% hydrochloric acid solution. The product was then extracted into methylene dichloride. The organic layer was separated, basified with a saturated sodium carbonate solution, dried over sodium sulfate, and distilled off to obtain a colorless oily product. The product was analyzed by chiral HPLC, ESI-MS and 1H NMR. (7.43g, 85% isolated yield, ee: >99%) ESI-MS was found to be 250.1 (M+). 1H NMR (CDCl3, 300MHz, ppm) delta 7.33-7.26 (m, 1H), 7.14-7.11 (d, J=7.2Hz, 1H), 7.07-7.02 (m, 2H), 3.48-3.34 (m, 3H), 3.06-2.99 (d, J=22.5Hz, 3H), 2.26 (s, 6H), 1.41-1.39 (d, J=6.9Hz, 3H), 1.27-1.17 (m, 3H).

Reference： [1]Tetrahedron Asymmetry,2013,vol. 24,p. 374 - 379

47
[ 1162673-62-2 ]
[ 123441-03-2 ]

Reference： [1]Patent: US2014/73809,2014,A1
[2]Patent: EP2711354,2014,A1

48
[ 1412902-91-0 ]
[ 123441-03-2 ]

Reference： [1]Patent: US2014/73809,2014,A1
[2]Patent: EP2711354,2014,A1

49
[ 1412902-83-0 ]
[ 123441-03-2 ]

Yield	Reaction Conditions	Operation in experiment
85%	With palladium 10% on activated carbon; hydrogen; potassium carbonate; In methanol; at 20℃; under 3800.26 Torr; for 8h;	Mix 10 g (0.02 mol) of (S)-1-(3-(ethyl(methyl)carbamoyloxy)phenyl)-N,N-dimethyl-N-((S)-1-phenylethyl)ethanaminium iodide (formula IX) obtained in Embodiment 14 with 100 ml of methanol, 4.1 g (0.03 mol) of potassium carbonate, 2 g Pd / C (10% mass), and add the mixture to a 250 ml hydrogenation reactor, set 5atm, and let it react for 8 hours when the internal temperature is 20 C. Open the reactor and obtain the mixture. Filter out Pd / C, reduced pressure to recover the solvent. Then add 50 ml of water before adding carbonate sodium in portions while adjusting pH to 8. Extracted with ethyl acetate (60 ml x 2), combine the organic layer and wash it with 15 ml of water. Dry with anhydrous magnesium sulfate and filter, and reduce the pressure to recover the solvent and receive 6.5 g pale yellow liquid. Distillation under reduced pressure: 1-1 .5 kpa, collect the 128-133 C fraction 4.3 g, yield 85%. Optical rotation [alpha] 20D =-32.1(C = 5, ethanol). 1HNMR (CDCl3) delta ppm: 1.22 (m,3H), 1.35 (q,3H), 2.20 (s,6H), 3.02 (d,3H), 3.25 (m,1H), 3.44 (s,2H), 7.05 (m,3H), 7.27 (m,1H); MS (ESI) m/z: 251.2 ([M+1]+).
4.3 g	With palladium 10% on activated carbon; hydrogen; potassium carbonate; In methanol; at 20℃; under 3800.26 Torr; for 8h;	Embodiment 20 The preparation of (S)-3-(1-(dimethylamino)ethyl)phenyl ethyl(methyl)carbamate (formula X) [0069] Mix 10 g (0.02 mol) of (S)-1-(3-(ethyl(methyl)carbamoyloxy)phenyl)-N,N-dimethyl-N-((S)-1-phenylethyl)ethanaminium iodide (formula IX) obtained in Embodiment 14 with 100 ml of methanol, 4.1 g (0.03 mol) of potassium carbonate, 2 g Pd/C (10% mass), and add the mixture to a 250 ml hydrogenation reactor, set 5 atm, and let it react for 8 hours when the internal temperature is 20 C. Open the reactor and obtain the mixture. Filter out Pd/C, reduced pressure to recover the solvent. Then add 50 ml of water before adding carbonate sodium in portions while adjusting pH to 8. Extracted with ethyl acetate (60 ml×2), combine the organic layer and wash it with 15 ml of water. Dry with anhydrous magnesium sulfate and filter, and reduce the pressure to recover the solvent and receive 6.5 g pale yellow liquid. [0070] Distillation under reduced pressure: 1-1.5 kpa, collect the 128-133 C. fraction 4.3 g, yield 85%. [0071] Optical rotation [alpha]20D=-32.1 (C=5, ethanol). [0072] 1HNMR (CDCl3) delta ppm: 1.22 (m, 3H), 1.35 (q, 3H), 2.20 (s, 6H), 3.02 (d, 3H), 3.25 (m, 1H), 3.44 (s, 2H), 7.05 (m, 3H), 7.27 (m, 1H); MS (ESI) m/z: 251.2 ([M+1]+).

Reference： [1]Patent: EP2711354,2014,A1 .Location in patent: Paragraph 0047
[2]Patent: US2014/73809,2014,A1 .Location in patent: Paragraph 0069-0072

50
[ 1412902-99-8 ]
[ 123441-03-2 ]

Reference： [1]Patent: US2014/73809,2014,A1
[2]Patent: EP2711354,2014,A1

51
[ 58105-38-7 ]
C₁₂H₁₃NO₂ [ No CAS ]
[ 123441-03-2 ]

Yield	Reaction Conditions	Operation in experiment
69%	With (R)-((4,4?-bi-1,3-benzodioxole)-5,5?-diyl)bis(bis(3,5-di-t-butyl-4-methoxyphenyl))phosphine; diethoxymethylane; copper diacetate; In tetrahydrofuran; isopropyl alcohol; at 20℃; for 18h;Sealed tube; Inert atmosphere; Schlenk technique;	General procedure: A typical procedure for the copper-catalysed reductive hydroamination of alkynes 1is as follows (all reactions were set up on the benchtop using a standard Schlenktechnique). An oven-dried screw-top reaction tube equipped with a magnetic stir barwas charged with Cu(OAc)2 (3.6 mg, 0.02 mmol, 2 mol%) and (R)-L4 (26 mg,0.022 mmol, 2.2 mol%). The reaction tube was sealed with a screw-cap septum, thenevacuated and backfilled with argon (this process was repeated a total of three times).Anhydrous THF (0.5 ml) and hydrosilane 3 (0.64 ml, 4.0 mmol, 4.0 equiv.) wereadded sequentially via syringe. The resulting mixture was stirred at roomtemperature (RT) for 15 min and the colour of the mixture changed from blue toorange. A second oven-dried screw-top reaction tube equipped with a stir bar wascharged with alkyne substrate 1a (178 mg, 1.0 mmol, 1.0 equiv.) and hydroxylamine ester 2a (381 mg, 1.2 mmol, 1.2 equiv.). The reaction tube was sealed with a screwcapseptum, and then evacuated and backfilled with argon (this process was repeateda total of three times). Anhydrous THF (0.5 ml) and EtOH (88 mul, 1.5 mmol,1.5 equiv.) were added, followed by dropwise addition of the catalyst solution fromthe first vial to the stirred reaction mixture at RT. The reaction mixture was thenheated at 40 C for 18 h. After cooling to RT, the reaction was quenched by additionof EtOAc and a saturated aqueous solution of Na2CO3. The phases were separated,the organic phase was concentrated, and product 5a was purified by flash columnchromatography. The e.e. of each product was determined by HPLC analysis usingchiral stationary phases. All new compounds were fully characterized (seeSupplementary Information).

Reference： [1]Nature Chemistry,2015,vol. 7,p. 38 - 44

52
[ 118761-92-5 ]
[ 123441-03-2 ]

Reference： [1]Angewandte Chemie - International Edition,2015,vol. 54,p. 11852 - 11856
Angew. Chem.,2015,vol. 127,p. 12019 - 12023,5

53
(S)-N-(tert-butoxycarbonyl)-N-methyl-1-(3-methoxy)phenylethylamine [ No CAS ]
[ 123441-03-2 ]

Reference： [1]Angewandte Chemie - International Edition,2015,vol. 54,p. 11852 - 11856
Angew. Chem.,2015,vol. 127,p. 12019 - 12023,5
[2]Chemistry Letters,2019,vol. 48,p. 1065 - 1068

54
[ 42252-34-6 ]
[ 105601-04-5 ]
[ 123441-03-2 ]

Yield	Reaction Conditions	Operation in experiment
97.6%	With sodium carbonate; In acetone; for 8h;	(1) is added to the three-port flask 3 - (1 - (dimethyl-amino) ethyl) phenol (19.8g, 0 . 12mol) and acetone 130 ml, by adding 4.5g anhydrous sodium carbonate activated for a certain time, by adding Kabool carbamic chloride (15.9g, 0 . 13mol), reaction 8 hours, after recycling of acetone, adding dichloromethane 110 ml and water 150 ml, using hydrochloric acid to adjust pH to 3, extraction, removed the organic phase, the water layer by adding 150 ml dichloromethane, adding concentrated ammonia to pH 10, separating an aqueous layer, 100 mi washing organic phase, from the solvent by reduced pressure evaporation to dryness methylene chloride level, of free alkali to get the yellow liquid of Rivastigmine 29.3g, yield 97.6%.

Reference： [1]Patent: CN105439906,2016,A .Location in patent: Paragraph 0017; 0018

55
[ 105601-20-5 ]
(R)-3-(1-(dimethylamino)ethyl) phenylethyl(methyl)carbamate [ No CAS ]
[ 123441-03-2 ]

Reference： [1]Chirality,2018,vol. 30,p. 165 - 176

56
[ 105601-04-5 ]
[ 123441-03-2 ]

Reference： [1]Patent: CN106565543,2017,A

57
[ 105601-04-5 ]
[ 123441-03-2 ]

Reference： [1]Patent: CN106565543,2017,A

58
[ 1257519-35-9 ]
[ 124-40-3 ]
(R)-3-(1-(dimethylamino)ethyl) phenylethyl(methyl)carbamate [ No CAS ]
[ 123441-03-2 ]

Reference： [1]Chemistry - A European Journal,2018,vol. 24,p. 7410 - 7416

59
[ 121-71-1 ]
(R)-3-(1-(dimethylamino)ethyl) phenylethyl(methyl)carbamate [ No CAS ]
[ 123441-03-2 ]

Reference： [1]Chemistry - A European Journal,2018,vol. 24,p. 7410 - 7416
[2]Molecules,2018,vol. 23
[3]Molecules,2018,vol. 23

60
[ 855300-09-3 ]
(R)-3-(1-(dimethylamino)ethyl) phenylethyl(methyl)carbamate [ No CAS ]
[ 123441-03-2 ]

Reference： [1]Chemistry - A European Journal,2018,vol. 24,p. 7410 - 7416
[2]Molecules,2018,vol. 23
[3]Molecules,2018,vol. 23

61
[ 1222073-98-4 ]
(R)-3-(1-(dimethylamino)ethyl) phenylethyl(methyl)carbamate [ No CAS ]
[ 123441-03-2 ]

Reference： [1]Chemistry - A European Journal,2018,vol. 24,p. 7410 - 7416

62
[ 1176026-49-5 ]
[ 124-40-3 ]
(R)-3-(1-(dimethylamino)ethyl) phenylethyl(methyl)carbamate [ No CAS ]
[ 123441-03-2 ]

Reference： [1]Molecules,2018,vol. 23

63
C₂₅H₂₈N₂O₂ [ No CAS ]
(R)-3-(1-(dimethylamino)ethyl) phenylethyl(methyl)carbamate [ No CAS ]
[ 123441-03-2 ]

Reference： [1]Molecules,2018,vol. 23

Yield	Reaction Conditions	Operation in experiment
	With acetylthiocholine; 5,5'-dithiobis-(2-nitrobenzoic acid); recombinant human acetylcholinesterase; In aq. phosphate buffer; at 25℃;pH 7;Irradiation; Enzymatic reaction;Kinetics;	General procedure: Two protocols were employed to measure the rate constant k21. One used stopped-flow methods to accurately measure the approach to the carbamoylation steady state following mixing of enzyme and carbamate. A Hi-Tech SFA 20 stopped-flow apparatus thermostatted at 25 C was used to rapidly mix equal volumes (300 muL) of AChE in one syringe and acetylthiocholine, DTNB, and carbamate in the other. Final concentrations of acetylthiocholine and DTNB were 0.25mM and 2.0 mM,respectively. This higher than conventional concentration of DTNB was employed to insure that DTNB reaction with thiocholine was not rate limiting. Absorbance at 412 nm was recorded on a Varian Cary 3A spectrophotometer at fixed intervals of 33 msec. The second protocol for obtaining k21 measured the increase in enzyme activity as carbamoylated AChE slowly decarbamoylated. Since half times for decarbamoylation here were as long as weeks, the key to accurate measurements was precise determination of the fully decarbamoylated enzyme activity. The AChE was radio labeled to enable this determination. A calibration ratio of radio methylated AChE activity monitored spectrophotometrically with 0.5mM acetylthiocholine to radioactivity determined by scintillation counting was established for stock AChE solutions. In a typical assay an AChE sample was inactivated with a carbamate for at least an hour (overnight with N,N-diethylcarbamates N-diethylcarbamates), and unreacted carbamate was removed by adding 100 muL of the mix to a 1.5 ml G-50 Sephadex spin column. The columns were prepared freshly and were equilibrated with phosphate buffer prior to addition of the mix. Recovery of enzyme from the columns was monitored by scintillation counting, and an aliquot (50 muL) of the fraction with the highest enzyme concentration was added to 3.0 mL of assay buffer containing 0.1-1.0mM acetylthiocholine. Typically,0.2-8 h of reactivation showed some curvature in the Ellman trace and allowed fitting with Eq. (2), although some reactivation reactions with N,N-diethylcarbamates were extended to 24 h. Data fitting was conducted with k12 and t0 in Eq. (2) set to zero and vf=v0 k21/(k12 + k21) fixed as the predicted final velocity determined from scintillation counting and the calibration ratio. Values listed for k21 are means of n measurements with the standard error of the mean.

65
[ 1257519-35-9 ]
[ 124-40-3 ]
[ 123441-03-2 ]

Yield	Reaction Conditions	Operation in experiment
95%		Solution of compound hA from (5 gm 0.022 mol) in Methylene Dichloride 25 ml chilled to 0-5C. To this solution, Phosphorous tribromide (3.5 gm 0.012 mol) added and stirred for 2 hrs.Organic layer is distilled after water wash sodium carbonate solution. To residue ( 5 gm) addedMethylene Dichloride (50 ml) and Dimethyamine 40% solution (50 ml) at 0-5C. The reactionmass stined for 8 hrs.Organic layer is extracted in Ethyl acetate at alkaline medium. After evaporation of solvent (III)obtained 95% yield.Chiral HPLC: R isomer 10% 5 Isomer 90% HPLC purity: 95.52% (figures 11 and 12)

Reference： [1]Patent: WO2018/158674,2018,A1 .Location in patent: Page/Page column 12; 13

66
[ 855300-09-3 ]
[ 123441-03-2 ]

Reference： [1]Patent: WO2018/158674,2018,A1

67
(3aR,7aR)-1,3-diisopropyl-2-(((S)-1-(3-methoxyphenyl)ethyl)amino)octahydrobenzo[d][1,3,2]diazaphosphole 2-oxide [ No CAS ]
[ 123441-03-2 ]

Reference： [1]Chemistry Letters,2019,vol. 48,p. 1065 - 1068

68
C₂₀H₃₂N₃O₂P [ No CAS ]
[ 123441-03-2 ]

Reference： [1]Chemistry Letters,2019,vol. 48,p. 1065 - 1068

69
[ 218900-56-2 ]
[ 123441-03-2 ]

Reference： [1]Chemistry Letters,2019,vol. 48,p. 1065 - 1068

70
[ 77-92-9 ]
[ 123441-03-2 ]
rivastigmine citrate [ No CAS ]

Yield	Reaction Conditions	Operation in experiment
88%	In isopropyl alcohol; for 1h;Reflux;	Dissolving the free substance of carbaplatin in a 6-fold ratio of isopropanol solution,After heating to reflux to dissolve, add 1.2 times the crude moles of anhydrous citric acid.Stir and dissolve for 1 h. After cooling to room temperature, transfer to a cold water bath at 0-5 C.A white solid precipitated, and continued to crystallize for 5 h, filtered, and the filter cake was washed with isopropanol.Take out the filter cake and dry it in a vacuum drying box at 60 C under reduced pressure for 24 hours to obtain crude carbatine citrateYield: 90%, HPLC content: 99.2%Dissolve the crude product in 6 times the amount of isopropanol solution, add 0.02 times the crude amount of medicinal charcoal, 0.03 times the amount of insurance powder and heat to reflux and stir. Continue stirring for 1 hour, filter while hot, filter off the medicinal charcoal and insurance. Powder solid, collect mother liquor, cool down and recrystallize. When the temperature is lowered to 60 , add seeds of carbaplatin citrate, white solid precipitates, cool down to 0-5 , continue to stir and crystallize for 5h, filter, and wash with isopropyl alcohol. the filter cake, the filter cake was removed and dried under reduced pressure to obtain the final product 24h <strong>[123441-03-2]rivastigmin</strong>e citrate, 88% yield in a vacuum oven 60 , HPLC content of 99.8%.

Reference： [1]Patent: CN110272358,2019,A .Location in patent: Paragraph 0048-0052

71
[ 123441-03-2 ]
[ 123441-03-2 ]

Reference： [1],2020

72
rivastigmine hydrogen tartrate [ No CAS ]
[ 123441-03-2 ]

Reference： [1],2020

73
[ 23308-82-9 ]
[ 123441-03-2 ]

Reference： [1]Patent: US2020/95195,2020,A1

74
[ 89691-63-4 ]
[ 123441-03-2 ]

Reference： [1]Patent: US2020/95195,2020,A1
[2]Patent: US2020/95195,2020,A1
[3]Patent: US2020/95195,2020,A1

75
phthalic acid mono-[1-(3-methoxyphenyl)ethyl] ester [ No CAS ]
[ 123441-03-2 ]

Reference： [1]Patent: US2020/95195,2020,A1
[2]Patent: US2020/95195,2020,A1
[3]Patent: US2020/95195,2020,A1

76
phthalic acid mono-[1-(3-methoxyphenyl)ethyl] ester (R)-1-phenylethylamine [ No CAS ]
[ 123441-03-2 ]

Reference： [1]Patent: US2020/95195,2020,A1

77
[ 1222073-98-4 ]
[ 127-19-5 ]
[ 123441-03-2 ]

Yield	Reaction Conditions	Operation in experiment
		To a 100 ml RB flask, MDC (23 ml), ethyl-methyl-carbamic acid 3-(1-hydroxy-ethyl)-phenyl ester (2.24 g) and triethylamine (2.78 ml) were added and cooled the reaction mass -10 to 0 C. To the above reaction mixture, added methane sulfonyl chloride (1.1 ml) drop wise and stirred for 10 min. Purged DMA gas through the reaction mixture at 25-30 C. for 30 min followed by adjusted the pH 1 to 2 by conc. HCl. Layers were separated, organic layer was extracted with DM water. Combined the aqueous layers, basify with 1:1 NaOH and extracted with ethyl acetate. Ethyl acetate was dried over anhydrous Na2SO4 and distilled out ethyl acetate to obtained 2.15 g of Rivastigmine base (Yield: 97%, HPLC: 96.94%, Chiral HPLC: 89.76%).

Reference： [1]Patent: US2020/95195,2020,A1 .Location in patent: Paragraph 0085

78
phthalic acid mono-[1-(3-methoxyphenyl)ethyl]ester (R)-(+)-α-methyl-1-naphthalenemethylamine salt [ No CAS ]
[ 123441-03-2 ]

Reference： [1]Patent: US2020/95195,2020,A1

79
phthalic acid mono-[1-(3-methoxyphenyl)ethyl]ester (R)-(+)-1-phenylpropylamine [ No CAS ]
[ 123441-03-2 ]

Reference： [1]Patent: US2020/95195,2020,A1

80
[ 586-37-8 ]
[ 123441-03-2 ]

Reference： [1]Patent: US2020/95195,2020,A1
[2]Patent: US2020/95195,2020,A1
[3]Patent: US2020/95195,2020,A1

81
[ 73183-34-3 ]
[ 123441-03-2 ]
C₂₀H₃₃BN₂O₄ [ No CAS ]

Reference： [1]Journal of Organic Chemistry,2020,vol. 85,p. 3596 - 3604

82
[ CAS Unavailable ]
[ 123441-03-2 ]
[ 2553319-98-3 ]

Yield	Reaction Conditions	Operation in experiment
33%	With tert.-butylhydroperoxide; cobalt‑copper ferrite In methanol; acetic acid at 20℃; for 2.5h;	2.3. General procedure for amination reaction General procedure: A glass tube was charged with amine (0.5 mmol), NaCN (0.6 mmol), MeOH/acetic acid: 0.8 mL/0.2 mL, and CoCuFe2O4 (5 mol%). The reaction mixture was stirred at room temperature, and TBHP (1.25 mmol, 70 wt%) was added dropwise. The reaction was monitored by TLC (EtOAc/n-hexane, 1:4). In each case, after completion, the catalyst was recovered by employing an external magnet and the mixture was diluted with ethyl acetate and water. The organic layer was washed with brine, dried over MgSO4, and concentrated under reduced pressure using a rotary evaporator. The residue was purified by column chromatography on silica gel (n-hexane-EtOAc, 4:1). The products were known compounds and were identified by comparison of their NMR spectra with those of authentic samples [14,15].

Reference： [1]Heidarian, Mahdi; Moghaddam, Firouz Matloubi; Pourkaveh, Raheleh [Catalysis Communications, 2021, vol. 149]

83
[ CAS Unavailable ]
[ 123441-03-2 ]
[ CAS Unavailable ]

Yield	Reaction Conditions	Operation in experiment
91%	With 2,4,5,6‐tetra‐9H‐carbazol‐9‐yl‐1,3‐benzenedicarbonitrile; sodium acetate In N,N-dimethyl-formamide at 20℃; for 16h; Irradiation; Inert atmosphere; diastereoselective reaction;

Reference： [1]Zhang, Yueteng; Ji, Peng; Gao, Feng; Huang, He; Zeng, Fanxun; Wang, Wei [ACS Catalysis, 2021, vol. 11, # 2, p. 998 - 1007]

Purity	Size	Price	VIP Price	USA Stock *0-1 Day	Global Stock *5-7 Days	Quantity
{[ item.p_purity ]}	{[ item.pr_size ]}	{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]}	{[ getRatePrice(item.pr_usd, 1,1) ]}	Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]}	{[ item.pr_usastock ]}	Inquiry -	{[ item.pr_chinastock ]}	Inquiry -

CAS No. :	123441-03-2	MDL No. :	MFCD00871496
Formula :	C₁₄H₂₂N₂O₂	Boiling Point :	-
Linear Structure Formula :	-	InChI Key :	XSVMFMHYUFZWBK-NSHDSACASA-N
M.W :	250.34	Pubchem ID :	77991
Synonyms :	S-Rivastigmine;SDZ-ENA 713;Exelon	Chemical Name :	(S)-3-(1-(Dimethylamino)ethyl)phenyl ethyl(methyl)carbamate

Num. heavy atoms :	18
Num. arom. heavy atoms :	6
Fraction Csp3 :	0.5
Num. rotatable bonds :	6
Num. H-bond acceptors :	3.0
Num. H-bond donors :	0.0
Molar Refractivity :	73.12
TPSA :	32.78 Å²

GI absorption :	High
BBB permeant :	Yes
P-gp substrate :	No
CYP1A2 inhibitor :	No
CYP2C19 inhibitor :	No
CYP2C9 inhibitor :	No
CYP2D6 inhibitor :	No
CYP3A4 inhibitor :	No
Log Kp (skin permeation) :	-6.2 cm/s

Log Po/w (iLOGP) :	3.21
Log Po/w (XLOGP3) :	2.29
Log Po/w (WLOGP) :	2.44
Log Po/w (MLOGP) :	2.34
Log Po/w (SILICOS-IT) :	1.46
Consensus Log Po/w :	2.35

[ CAS No. 123441-03-2 ] {[proInfo.proName]}

Quality Control of [ 123441-03-2 ]

Related Doc. of [ 123441-03-2 ]

Product Details of [ 123441-03-2 ]

Calculated chemistry of [ 123441-03-2 ]

Physicochemical Properties

Pharmacokinetics

Lipophilicity

Druglikeness

Water Solubility

Medicinal Chemistry

Safety of [ 123441-03-2 ]

Application In Synthesis of [ 123441-03-2 ]

[ 123441-03-2 ] Synthesis Path-Upstream 1~2

[ 123441-03-2 ] Synthesis Path-Downstream 1~83

Similar Product of
[ 123441-03-2 ]

Precautionary Statements-General

Prevention

Response

Storage

Disposal

Physical hazards

Health hazards

Environmental hazards

Inquiry

Lipinski :	0.0
Ghose :	None
Veber :	0.0
Egan :	0.0
Muegge :	0.0
Bioavailability Score :	0.55

Log S (ESOL) :	-2.69
Solubility :	0.517 mg/ml ; 0.00206 mol/l
Class :	Soluble
Log S (Ali) :	-2.62
Solubility :	0.606 mg/ml ; 0.00242 mol/l
Class :	Soluble
Log S (SILICOS-IT) :	-3.15
Solubility :	0.176 mg/ml ; 0.000701 mol/l
Class :	Soluble

PAINS :	0.0 alert
Brenk :	0.0 alert
Leadlikeness :	0.0
Synthetic accessibility :	2.73

Signal Word:	Warning	Class:	N/A
Precautionary Statements:	P261-P305+P351+P338	UN#:	N/A
Hazard Statements:	H302-H315-H319-H335	Packing Group:	N/A
GHS Pictogram:

Precautionary Statements-General
Code	Phrase
P101	If medical advice is needed,have product container or label at hand.
P102	Keep out of reach of children.
P103	Read label before use
Prevention
Code	Phrase
P201	Obtain special instructions before use.
P202	Do not handle until all safety precautions have been read and understood.
P210	Keep away from heat/sparks/open flames/hot surfaces. - No smoking.
P211	Do not spray on an open flame or other ignition source.
P220	Keep/Store away from clothing/combustible materials.
P221	Take any precaution to avoid mixing with combustibles
P222	Do not allow contact with air.
P223	Keep away from any possible contact with water, because of violent reaction and possible flash fire.
P230	Keep wetted
P231	Handle under inert gas.
P232	Protect from moisture.
P233	Keep container tightly closed.
P234	Keep only in original container.
P235	Keep cool
P240	Ground/bond container and receiving equipment.
P241	Use explosion-proof electrical/ventilating/lighting/equipment.
P242	Use only non-sparking tools.
P243	Take precautionary measures against static discharge.
P244	Keep reduction valves free from grease and oil.
P250	Do not subject to grinding/shock/friction.
P251	Pressurized container: Do not pierce or burn, even after use.
P260	Do not breathe dust/fume/gas/mist/vapours/spray.
P261	Avoid breathing dust/fume/gas/mist/vapours/spray.
P262	Do not get in eyes, on skin, or on clothing.
P263	Avoid contact during pregnancy/while nursing.
P264	Wash hands thoroughly after handling.
P265	Wash skin thouroughly after handling.
P270	Do not eat, drink or smoke when using this product.
P271	Use only outdoors or in a well-ventilated area.
P272	Contaminated work clothing should not be allowed out of the workplace.
P273	Avoid release to the environment.
P280	Wear protective gloves/protective clothing/eye protection/face protection.
P281	Use personal protective equipment as required.
P282	Wear cold insulating gloves/face shield/eye protection.
P283	Wear fire/flame resistant/retardant clothing.
P284	Wear respiratory protection.
P285	In case of inadequate ventilation wear respiratory protection.
P231 + P232	Handle under inert gas. Protect from moisture.
P235 + P410	Keep cool. Protect from sunlight.
Response
Code	Phrase
P301	IF SWALLOWED:
P304	IF INHALED:
P305	IF IN EYES:
P306	IF ON CLOTHING:
P307	IF exposed:
P308	IF exposed or concerned:
P309	IF exposed or if you feel unwell:
P310	Immediately call a POISON CENTER or doctor/physician.
P311	Call a POISON CENTER or doctor/physician.
P312	Call a POISON CENTER or doctor/physician if you feel unwell.
P313	Get medical advice/attention.
P314	Get medical advice/attention if you feel unwell.
P315	Get immediate medical advice/attention.
P320
P302 + P352	IF ON SKIN: wash with plenty of soap and water.
P321
P322
P330	Rinse mouth.
P331	Do NOT induce vomiting.
P332	IF SKIN irritation occurs:
P333	If skin irritation or rash occurs:
P334	Immerse in cool water/wrap n wet bandages.
P335	Brush off loose particles from skin.
P336	Thaw frosted parts with lukewarm water. Do not rub affected area.
P337	If eye irritation persists:
P338	Remove contact lenses, if present and easy to do. Continue rinsing.
P340	Remove victim to fresh air and keep at rest in a position comfortable for breathing.
P341	If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing.
P342	If experiencing respiratory symptoms:
P350	Gently wash with plenty of soap and water.
P351	Rinse cautiously with water for several minutes.
P352	Wash with plenty of soap and water.
P353	Rinse skin with water/shower.
P360	Rinse immediately contaminated clothing and skin with plenty of water before removing clothes.
P361	Remove/Take off immediately all contaminated clothing.
P362	Take off contaminated clothing and wash before reuse.
P363	Wash contaminated clothing before reuse.
P370	In case of fire:
P371	In case of major fire and large quantities:
P372	Explosion risk in case of fire.
P373	DO NOT fight fire when fire reaches explosives.
P374	Fight fire with normal precautions from a reasonable distance.
P376	Stop leak if safe to do so. Oxidising gases (section 2.4) 1
P377	Leaking gas fire: Do not extinguish, unless leak can be stopped safely.
P378
P380	Evacuate area.
P381	Eliminate all ignition sources if safe to do so.
P390	Absorb spillage to prevent material damage.
P391	Collect spillage. Hazardous to the aquatic environment
P301 + P310	IF SWALLOWED: Immediately call a POISON CENTER or doctor/physician.
P301 + P312	IF SWALLOWED: call a POISON CENTER or doctor/physician IF you feel unwell.
P301 + P330 + P331	IF SWALLOWED: Rinse mouth. Do NOT induce vomiting.
P302 + P334	IF ON SKIN: Immerse in cool water/wrap in wet bandages.
P302 + P350	IF ON SKIN: Gently wash with plenty of soap and water.
P303 + P361 + P353	IF ON SKIN (or hair): Remove/Take off Immediately all contaminated clothing. Rinse SKIN with water/shower.
P304 + P312	IF INHALED: Call a POISON CENTER or doctor/physician if you feel unwell.
P304 + P340	IF INHALED: Remove victim to fresh air and Keep at rest in a position comfortable for breathing.
P304 + P341	IF INHALED: If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing.
P305 + P351 + P338	IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing.
P306 + P360	IF ON CLOTHING: Rinse Immediately contaminated CLOTHING and SKIN with plenty of water before removing clothes.
P307 + P311	IF exposed: call a POISON CENTER or doctor/physician.
P308 + P313	IF exposed or concerned: Get medical advice/attention.
P309 + P311	IF exposed or if you feel unwell: call a POISON CENTER or doctor/physician.
P332 + P313	IF SKIN irritation occurs: Get medical advice/attention.
P333 + P313	IF SKIN irritation or rash occurs: Get medical advice/attention.
P335 + P334	Brush off loose particles from skin. Immerse in cool water/wrap in wet bandages.
P337 + P313	IF eye irritation persists: Get medical advice/attention.
P342 + P311	IF experiencing respiratory symptoms: call a POISON CENTER or doctor/physician.
P370 + P376	In case of fire: Stop leak if safe to Do so.
P370 + P378	In case of fire:
P370 + P380	In case of fire: Evacuate area.
P370 + P380 + P375	In case of fire: Evacuate area. Fight fire remotely due to the risk of explosion.
P371 + P380 + P375	In case of major fire and large quantities: Evacuate area. Fight fire remotely due to the risk of explosion.
Storage
Code	Phrase
P401
P402	Store in a dry place.
P403	Store in a well-ventilated place.
P404	Store in a closed container.
P405	Store locked up.
P406	Store in corrosive resistant/ container with a resistant inner liner.
P407	Maintain air gap between stacks/pallets.
P410	Protect from sunlight.
P411
P412	Do not expose to temperatures exceeding 50 oC/ 122 oF.
P413
P420	Store away from other materials.
P422
P402 + P404	Store in a dry place. Store in a closed container.
P403 + P233	Store in a well-ventilated place. Keep container tightly closed.
P403 + P235	Store in a well-ventilated place. Keep cool.
P410 + P403	Protect from sunlight. Store in a well-ventilated place.
P410 + P412	Protect from sunlight. Do not expose to temperatures exceeding 50 oC/122oF.
P411 + P235	Keep cool.
Disposal
Code	Phrase
P501	Dispose of contents/container to ...
P502	Refer to manufacturer/supplier for information on recovery/recycling

[ CAS No. 123441-03-2 ] {[proInfo.proName]}

Quality Control of [ 123441-03-2 ]

Related Doc. of [ 123441-03-2 ]

Product Details of [ 123441-03-2 ]

Calculated chemistry of [ 123441-03-2 ]

Physicochemical Properties

Pharmacokinetics

Lipophilicity

Druglikeness

Water Solubility

Medicinal Chemistry

Safety of [ 123441-03-2 ]

Application In Synthesis of [ 123441-03-2 ]

[ 123441-03-2 ] Synthesis Path-Upstream 1~2

[ 123441-03-2 ] Synthesis Path-Downstream 1~83

Similar Product of [ 123441-03-2 ]

Precautionary Statements-General

Prevention

Response

Storage

Disposal

Physical hazards

Health hazards

Environmental hazards

Inquiry

Similar Product of
[ 123441-03-2 ]